<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">ACS Chem Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">ACS Chem Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">cn</journal-id>
<journal-id journal-id-type="coden">acncdm</journal-id>
<journal-title-group>
<journal-title>ACS Chemical Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1948-7193</issn>
<publisher>
<publisher-name>American Chemical
Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30200754</article-id>
<article-id pub-id-type="pmc">6337688</article-id>
<article-id pub-id-type="doi">10.1021/acschemneuro.8b00231</article-id>
<article-categories>
<subj-group>
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Bypassing Glutamic Acid Decarboxylase 1 (Gad1) Induced
Craniofacial Defects with a Photoactivatable Translation Blocker Morpholino</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="ath1">
<name>
<surname>O’Connor</surname>
<given-names>Matthew
J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">†</xref>
</contrib>
<contrib contrib-type="author" id="ath2">
<name>
<surname>Beebe</surname>
<given-names>Lindsey L.</given-names>
</name>
<xref ref-type="aff" rid="aff2">‡</xref>
</contrib>
<contrib contrib-type="author" id="ath3">
<name>
<surname>Deodato</surname>
<given-names>Davide</given-names>
</name>
<xref ref-type="aff" rid="aff1">†</xref>
</contrib>
<contrib contrib-type="author" id="ath4">
<name>
<surname>Ball</surname>
<given-names>Rebecca E.</given-names>
</name>
<xref ref-type="aff" rid="aff3">§</xref>
</contrib>
<contrib contrib-type="author" id="ath5">
<name>
<surname>Page</surname>
<given-names>A. Tyler</given-names>
</name>
<xref ref-type="aff" rid="aff3">§</xref>
</contrib>
<contrib contrib-type="author" id="ath6">
<name>
<surname>VanLeuven</surname>
<given-names>Ariel J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">§</xref>
</contrib>
<contrib contrib-type="author" id="ath7">
<name>
<surname>Harris</surname>
<given-names>Kyle T.</given-names>
</name>
<xref ref-type="aff" rid="aff5">⊥</xref>
</contrib>
<contrib contrib-type="author" id="ath8">
<name>
<surname>Park</surname>
<given-names>Sungdae</given-names>
</name>
<xref ref-type="aff" rid="aff2">‡</xref>
</contrib>
<contrib contrib-type="author" id="ath9">
<name>
<surname>Hariharan</surname>
<given-names>Vani</given-names>
</name>
<xref ref-type="aff" rid="aff3">§</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="ath10">
<name>
<surname>Lauderdale</surname>
<given-names>James D.</given-names>
</name>
<xref ref-type="other" rid="cor2">*</xref>
<xref ref-type="aff" rid="aff3">§</xref>
<xref ref-type="aff" rid="aff4">∥</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="ath11">
<name>
<surname>Dore</surname>
<given-names>Timothy M.</given-names>
</name>
<xref ref-type="other" rid="cor1">*</xref>
<xref ref-type="aff" rid="aff1">†</xref>
<xref ref-type="aff" rid="aff5">⊥</xref>
</contrib>
<aff id="aff1"><label>†</label><institution>New
York University Abu Dhabi</institution>, PO Box 129188, Abu Dhabi, <country>United Arab Emirates</country></aff>
<aff id="aff2"><label>‡</label>Department
of Genetics, <institution>University of Georgia</institution>, Athens, Georgia 30602, <country>United States</country></aff>
<aff id="aff3"><label>§</label>Department
of Cellular Biology, <institution>University of Georgia</institution>, Athens, Georgia 30602, <country>United States</country></aff>
<aff id="aff4"><label>∥</label>Neuroscience
Division
of the Biomedical and Health Sciences Institute, Athens, Georgia 30602, <country>United States</country></aff>
<aff id="aff5"><label>⊥</label>Department
of Chemistry, <institution>University of Georgia</institution>, Athens, Georgia 30602 <country>United States</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>(T.M.D.) Phone: <phone>+971 2 628
4762</phone>. E-mail: <email>timothy.dore@nyu.edu</email>.</corresp>
<corresp id="cor2"><label>*</label>(J.D.L.) Phone: <phone>+1 706 542
7433</phone>. E-mail: <email>jdlauder@uga.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>09</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<day>16</day>
<month>01</month>
<year>2019</year>
</pub-date>
<volume>10</volume>
<issue>1</issue>
<fpage>266</fpage>
<lpage>278</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>05</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>09</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 American Chemical Society</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>American Chemical Society</copyright-holder>
<license>
<license-p>This is an open access article published under an ACS AuthorChoice <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html" xmlns:xlink="http://www.w3.org/1999/xlink">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p>
</license>
</permissions>
<abstract>
<p content-type="toc-graphic">
<graphic id="ab-tgr1" xlink:href="cn-2018-00231t_0013" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</p>
<p>γ-Amino
butyric acid (GABA) mediated signaling is critical
in the central and enteric nervous systems, pancreas, lungs, and other
tissues. It is associated with many neurological disorders and craniofacial
development. Glutamic acid decarboxylase (GAD) synthesizes GABA from
glutamate, and knockdown of the <italic>gad1</italic> gene results
in craniofacial defects that are lethal in zebrafish. To bypass this
and enable observation of the neurological defects resulting from
knocking down <italic>gad1</italic> expression, a photoactivatable
morpholino oligonucleotide (MO) against <italic>gad1</italic> was
prepared by cyclization with a photocleavable linker rendering the
MO inactive. The cyclized MO was stable in the dark and toward degradative
enzymes and was completely linearized upon brief exposure to 405 nm
light. In the course of investigating the function of the ccMOs in
zebrafish, we discovered that zebrafish possess paralogous <italic>gad1</italic> genes, <italic>gad1a</italic> and <italic>gad1b</italic>. A <italic>gad1b</italic> MO injected at the 1–4 cell stage
caused severe morphological defects in head development, which could
be bypassed, enabling the fish to develop normally, if the fish were
injected with a photoactivatable, cyclized <italic>gad1b</italic> MO
and grown in the dark. At 1 day post fertilization (dpf), light activation
of the <italic>gad1b</italic> MO followed by observation at 3 and
7 dpf led to increased and abnormal electrophysiological brain activity
compared to wild type animals. The photocleavable linker can be used
to cyclize and inactivate any MO, and represents a general strategy
to parse the function of developmentally important genes in a spatiotemporal
manner.</p>
</abstract>
<kwd-group>
<kwd>Glutamic
acid decarboxylase</kwd>
<kwd>γ-amino butyric acid</kwd>
<kwd>GABAergic signaling</kwd>
<kwd>photoactivated morpholino</kwd>
<kwd>(8-bromo-7-hydroxyquinolin-2-yl)methyl</kwd>
<kwd>(8-cyano-7-hydroxyquinolin-2-yl)methyl</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>document-id-old-9</meta-name>
<meta-value>cn8b00231</meta-value>
</custom-meta>
<custom-meta>
<meta-name>document-id-new-14</meta-name>
<meta-value>cn-2018-00231t</meta-value>
</custom-meta>
<custom-meta>
<meta-name>ccc-price</meta-name>
<meta-value></meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>Introduction</title>
<p>γ-Amino
butyric acid (GABA) mediated signaling is important
in a number of neural and non-neural tissues in the vertebrate. Best
known as an inhibitory neurotransmitter in the central nervous system
(CNS), disruption in GABAergic signaling is associated with several
neurological disorders, including epilepsy,<sup><xref ref-type="bibr" rid="ref1">1</xref>−<xref ref-type="bibr" rid="ref3">3</xref></sup> schizophrenia,<sup><xref ref-type="bibr" rid="ref4">4</xref>−<xref ref-type="bibr" rid="ref7">7</xref></sup> autism,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> spastic quadriplegic cerebral
palsy 1,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> and stiff-person syndrome.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Outside of the CNS, GABA and GABAergic signaling
have been reported in the enteric nervous system<sup><xref ref-type="bibr" rid="ref11">11</xref>−<xref ref-type="bibr" rid="ref14">14</xref></sup> and for tissues including the
pancreas<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> and lungs,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> among
others.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> GABAergic signaling in the lungs
plays a critical role in asthma,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and
disruption of GABAergic signaling in the pancreas appears to be causal
for insulin-dependent diabetes mellitus.<sup><xref ref-type="bibr" rid="ref19">19</xref>−<xref ref-type="bibr" rid="ref21">21</xref></sup></p>
<p>GABAergic
signaling has also been implicated in craniofacial development
in mammals. GABA is synthesized from glutamic acid by a reaction catalyzed
by the enzyme glutamic acid decarboxylase (GAD, IUBMB Enzyme Nomenclature
EC 4.1.1.15).<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> In mammals, the majority
of GAD protein exists as two molecularly distinct forms with molecular
weights of 67 and 65 kDa, known as GAD<sub>67</sub> and GAD<sub>65</sub>, which are encoded by the <italic>GAD1</italic> and <italic>GAD2</italic> genes, respectively.<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> Whereas both enzymes make GABA
from glutamate, they are found in different subcellular locations
and at different expression levels in the same tissue, suggesting
that each enzyme contributes differently to cell and neuron function.<sup><xref ref-type="bibr" rid="ref25">25</xref>−<xref ref-type="bibr" rid="ref31">31</xref></sup><italic>GAD</italic> genes are also expressed in juveniles and adults,
which indicates important roles in neuronal function and developmental
processes.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref32">32</xref>−<xref ref-type="bibr" rid="ref34">34</xref></sup> Because GAD
converts an excitatory neurotransmitter into an inhibitory one, its
function (or mis-function) has tremendous implications in the regulation
of the nervous system. During development in mice and humans, loss-of-function
mutations in the <italic>GAD1</italic> gene, but not <italic>GAD2</italic>, or in the <italic>GABA<sub>A</sub> receptor</italic>, <italic>beta
3</italic> (<italic>GABRB3</italic>) subunit have been reported to
result in oral clefts (e.g., cleft lip and cleft palate), indicating
that GABAergic signaling through GABA<sub>A</sub> is required for
normal palate development in mammals.<sup><xref ref-type="bibr" rid="ref35">35</xref>−<xref ref-type="bibr" rid="ref40">40</xref></sup></p>
<p>We are studying the role of GABAergic signaling in the developing
zebrafish, with emphasis on the CNS. Zebrafish are an important and
widely used model system for studying normal and abnormal physiology
of vertebrates, especially embryonic development. Control of gene
expression in the zebrafish is an invaluable tool for studying physiological
processes.<sup><xref ref-type="bibr" rid="ref41">41</xref>−<xref ref-type="bibr" rid="ref43">43</xref></sup> Genes important to development often have multiple
functions at different life cycle stages. Mutations or techniques
that interfere with early gene function often preclude the study of
later functions. Further, irreversible changes to the genome made
through knockout or transgenic organisms can result in compensation
or embryonic lethality. An efficient method for manipulating gene
expression in a spatiotemporal fashion would be a useful tool for
investigating stage or tissue-specific roles of developmental genes.</p>
<p>In zebrafish, gene function can be disrupted by injecting embryos
prior to the 16-cell stage with synthetic oligonucleotides called
morpholino oligonucleotides (MOs),<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> which
contain DNA bases linked through a backbone consisting of phosphorodiamidates
and morpholine. The difference in structure renders the MO resistant
to nucleases, while still being able to hybridize to complementary
mRNA sequences with high affinity and specificity. Depending on whether
the MO binds to intron/exon sequences or near the start codon, RNA
splicing or translation is blocked. The resulting gene silencing can
last up to 4 days.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> MOs are incredibly
important for genetic studies in zebrafish.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup></p>
<p>Standard MOs induce global and immediate gene silencing in
zebrafish,
which limits their experimental utility. A photoactivatable MO provides
control over the timing and location of gene silencing, enabling the
study of the role of a gene’s expression at different stages
of embryonic development. Photoactivatable negatively charged peptide
nucleic acids (ncPNAs) and oligonucleotides have also been used to
knock down gene expression in zebrafish,<sup><xref ref-type="bibr" rid="ref46">46</xref>−<xref ref-type="bibr" rid="ref48">48</xref></sup> but MOs are
more widely used in this important model organism. The first strategy
reported for regulating the action of MOs in zebrafish with light
used a hairpin linker<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> that hybridized
an inhibitor strand to the MO to inactivate it.<sup><xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup> Photolysis of the linker enabled dissociation of the MO from the
inhibitor, releasing it to find its mRNA target. If the photocleaving
element is (8-bromo-7-hydroxyquinolin-2-yl)methyl (BHQ),<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> then two-photon excitation (2PE) activates the MO.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> PhotoMorphs use RNA as the inhibitor strand, which is photochemically
cleaved into two pieces that bind poorly to the MO strand.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Placing the photocleavage site in the middle
of an MO strand enables destruction of the MO with light, leading
to activation of gene expression at different time points in development.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> The bases on an MO strand can be directly photocaged
with photoremovable protecting groups (PPGs), which blocks hybridization
with the target mRNA, although the technique requires at least four
PPGs to be distributed on the MO strand to prevent premature binding
of the MO to the mRNA.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup></p>
<p>To eliminate
the need for an inhibitor strand and ease of synthesis,
Chen et al. created a caged cyclic morpholino (ccMO) against <italic>no tail-a</italic> (<italic>ntla</italic>).<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> Cyclization of the MO through a photocleavable linker to generate
a ccMO prevents the MO from binding to its mRNA target (<xref ref-type="fig" rid="fig1">Figure <xref ref-type="fig" rid="fig1">1</xref></xref>). A dimethoxynitrobenzyl (DMNB)
PPG mediates the photocleavage of the linker. Tang et al. reported
a ccMO against β-catenin-2 and <italic>ntl</italic> using a
linker comprised of a nitrophenethyl (NPE) PPG.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Subsequently, Chen and Deiters reported wavelength selective
activation of ccMOs against <italic>ntla</italic>, <italic>spade tail</italic> (<italic>spt</italic>), and <italic>floating head</italic> (<italic>flh</italic>) using nitrobenzyl (NB) and diethylaminocoumarin (DEACM)
based linkers for short (365 nm) and long-wavelength (470 nm) MO activation,
respectively.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> Dmochowski et al. reported
a ruthenium-based photolinker, RuBEP, for ccMOs against <italic>chordin</italic> (<italic>chd</italic>) and <italic>ntl</italic> that can be activated
at 450 nm.<sup><xref ref-type="bibr" rid="ref106">106</xref></sup></p>
<fig id="fig1" position="float">
<label>Figure 1</label>
<caption>
<p>Photoactivation of a
caged, cyclic morpholino (ccMO).</p>
</caption>
<graphic id="gr1" position="float" xlink:href="cn-2018-00231t_0001" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<p>We prepared ccMOs against the <italic>gad1</italic> and <italic>gad2</italic> genes using a variation on Chen’s linker design
that employs our quinoline-based PPGs BHQ and (8-cyano-7-hydroxyquinolin-2-yl)methyl
(CyHQ),<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> and demonstrated
their use in conditionally manipulating <italic>gad</italic> gene
function in the developing zebrafish embryo (see <xref ref-type="other" rid="sec4">Methods</xref> for genetic nomenclature used in this report). Using
BHQ and CyHQ expands the number of PPGs that can be used to prepare
ccMOs activated with rapid photolysis kinetics (&lt;1 μs time
scale) using low intensity light to minimize phototoxicity. Further,
BHQ and CyHQ can be photolyzed through two-photon excitation (2PE),
which would enable ccMO activation using deeply penetrating IR wavelengths.
In the course of investigating the function of the ccMOs in zebrafish,
we discovered that zebrafish possess paralogous <italic>gad1</italic> genes (VanLeuven, A. J.; Ball, R. E.; Gunderson, C. E.; Lauderdale,
J. D., submitted). Other fish species have two <italic>gad1</italic> genes, designated as <italic>gad1a</italic> and <italic>gad1b</italic>, and a single <italic>gad2</italic> gene.<sup><xref ref-type="bibr" rid="ref61">61</xref>−<xref ref-type="bibr" rid="ref63">63</xref></sup> In zebrafish, <italic>gad1a</italic> is located on chromosome 9, <italic>gad1b</italic> on chromosome 6, and <italic>gad2</italic> on chromosome 24 (VanLeuven,
A. J.; Ball, R. E.; Gunderson, C. E.; Lauderdale, J. D., submitted).
Our <italic>gad</italic> MOs are designed to bind to the translation
start sites of their respective transcript units. The <italic>gad1</italic> MO is directed against <italic>gad1b</italic>, which is broadly
expressed in the developing zebrafish CNS.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref64">64</xref>−<xref ref-type="bibr" rid="ref66">66</xref></sup></p>
</sec>
<sec id="sec2">
<title>Results and Discussion</title>
<sec id="sec2.1">
<title>Preparation of ccMOs</title>
<p>Two versions of the photocleavable
linker were prepared: one from the BHQ PPG and the other from CyHQ.
The BHQ-based linker <bold>1a</bold> was prepared from the previously
reported benzenesulfonate-protected BHQ derivative <bold>5</bold> (<xref ref-type="scheme" rid="sch1">Scheme <xref ref-type="scheme" rid="sch1">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> The hydroxyl group in <bold>5</bold> was activated with
carbonyl diimidazole and subsequently treated with <italic>N</italic>,<italic>N′-</italic>dimethylethylene-diamine to extend the
chain. Treatment with base removed the benzenesulfonate and hydrolyzed
the methyl ester to give the acid <bold>6</bold>. The free secondary
amine of <bold>6</bold> was acylated with chloroacetyl chloride to
provide <bold>7</bold>, whose carboxylic acid could be activated for
coupling to the MO with disuccinimidyl carbonate, providing <bold>1a</bold>.</p>
<fig id="sch1" position="float">
<label>Scheme 1</label>
<caption>
<title>Synthesis of BHQ Linker <bold>1a</bold><sup><italic>a</italic></sup></title>
<p id="s1fn1">Reagents and conditions: (a)
carbonyl diimidazole, CH<sub>2</sub>Cl<sub>2</sub>, 15 min; (b) <italic>N</italic>,<italic>N′-</italic>dimethylethylene-diamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 15 min; (c) acetonitrile/0.4 N
NaOH(aq) (1:1), 12 h; (d) chloroacetyl chloride, DIEA, 15 min, then
TFA, H<sub>2</sub>O, 12 h; (e) disuccinimidyl carbonate, pyridine,
CH<sub>3</sub>CN, 12 h.</p>
</caption>
<graphic id="gr2" position="float" xlink:href="cn-2018-00231t_0009" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<p>Linker <bold>1b</bold> was prepared from CyHQ<sup><xref ref-type="bibr" rid="ref60">60</xref>,<xref ref-type="bibr" rid="ref67">67</xref></sup> by first protecting
the phenol with a MEM group to give <bold>8</bold>, which was oxidized
with selenium dioxide to aldehyde <bold>9</bold> (<xref ref-type="scheme" rid="sch2">Scheme <xref ref-type="scheme" rid="sch2">2</xref></xref>). An indium-mediated
Barbier reaction with allyl bromide produced homoallylic alcohol <bold>10</bold>, whose alkene could be oxidatively cleaved with osmium
tetroxide to aldehyde <bold>11</bold>. This aldehyde was too unstable
in air to be isolated so it was immediately reductively aminated to <bold>12</bold>, which was not purified, but quickly reacted with methyl
adipoyl chloride to afford methyl ester <bold>13</bold>. A similar
method as described for <bold>1a</bold> was used to convert <bold>13</bold> into <bold>1b</bold>. A three-step sequence to grow a second
arm of the linker from alcohol <bold>13</bold> provided <bold>14</bold>. Trifluoroacetic acid removed the MEM group from the phenol and
hydrolyzed the methyl ester, which could be converted to the succinimidyl
ester <bold>1b</bold> for coupling to a MO.</p>
<fig id="sch2" position="float">
<label>Scheme 2</label>
<caption>
<title>Synthesis of CyHQ
Linker <bold>1b</bold><sup><italic>a</italic></sup></title>
<p id="s2fn1">Reagents and conditions:
(a)
MEMCl, iPr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 3 h; (b)
SeO<sub>2</sub>, <italic>t</italic>-Bu-OOH, 1,4-dioxane, 45 °C,
3 h; (c) allyl bromide, indium, sat. NH<sub>4</sub>Cl(aq), THF, sonication,
55 °C, 90 min; (d) K<sub>2</sub>OsO<sub>4</sub>, 2,6-lutidine,
NaIO<sub>4</sub>, 1:1 THF/H<sub>2</sub>O, 12 h; (e) methylamine (2.0
M in MeOH), AcOH, NaBH(OAc)<sub>3</sub>, THF, 12 h; (f) methyl adipoyl
chloride, CH<sub>2</sub>Cl<sub>2</sub>, DIEA, 0 °C to rt, 6 h;
(g) carbonyl diimidazole, CH<sub>2</sub>Cl<sub>2</sub>, 10 min; (h) <italic>N</italic>,<italic>N′</italic>-dimethylethylenediamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 10 min; (i) chloroacetyl chloride,
DIEA, 0 °C, 4 h; (j) trifluoroacetic acid/water (1:1), 40 °C,
12 h; (k) disuccinimidyl carbonate, pyridine, CH<sub>3</sub>CN, 12
h.</p>
</caption>
<graphic id="gr3" position="float" xlink:href="cn-2018-00231t_0010" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<p>BHQ- and CyHQ-caged MOs against <italic>gad1b</italic><bold>4a-1</bold> and <bold>4b-1</bold> and <italic>gad2</italic><bold>4b-2</bold>, respectively, were prepared from
their respective linkers <bold>1a</bold> and <bold>1b</bold> (<xref ref-type="scheme" rid="sch3">Scheme <xref ref-type="scheme" rid="sch3">3</xref></xref>). Linker <bold>1a</bold> or <bold>1b</bold> was coupled
to the 5′-amine functionalized end of <italic>gad1b</italic> MO <bold>2</bold> through displacement of the succinimidyl ester
in sodium borate buffer (pH 8.5). After desalting, <bold>3a-1</bold>, <bold>3b-1</bold>, or <bold>3b-2</bold> was cyclized by reducing
the disulfide bond in situ with tris(2-carboxyethyl)phosphine (TCEP)
to the sulfhydryl, which displaced the chloride on <bold>3a-1</bold>, <bold>3b-1</bold>, or <bold>3b-2</bold> to form the BHQ- or CyHQ-cMO
(<bold>4a-1</bold>, <bold>4b-1</bold>, or <bold>4b-2</bold>) in ∼50%
yield after purification by size exclusion chromatography (NAP-5 column
eluting with a water mobile phase).</p>
<fig id="sch3" position="float">
<label>Scheme 3</label>
<caption>
<title>Preparation of ccMOs<sup><italic>a</italic></sup></title>
<p id="s3fn1">Reagents and conditions: (a)
0.1 M NaB<sub>4</sub>O<sub>7</sub>, pH 8.5, DMSO, functionalized MO
with 5′ amino and 3′ disulfide (<bold>2</bold>–<bold>1</bold> or <bold>2</bold>–<bold>2</bold>); (b) tris (2-carboxyethyl)phosphine
(TCEP), resin, 0.1 M Tris-HCl buffer, pH 8.4.</p>
</caption>
<graphic id="gr4" position="float" xlink:href="cn-2018-00231t_0011" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
</sec>
<sec id="sec2.2">
<title>Photochemical Activation of gad1b MO</title>
<p>Photolysis of
the ccMOs at 365 or 405 nm cleaved the linker, linearizing the cMO
(<xref ref-type="scheme" rid="sch4">Scheme <xref ref-type="scheme" rid="sch4">4</xref></xref>). Gel shift
assays were performed to determine the affinity of the <italic>gad1b</italic> CyHQ-protected cMO <bold>4b-1</bold> to its sequence specific target
both before and after photolysis (<xref ref-type="fig" rid="fig2">Figure <xref ref-type="fig" rid="fig2">2</xref></xref>). Migration of the DNA and the DNA with
the caged MO show bands commensurate with the 25 bp size of the fragment.
The photolyzed ccMO and the control DNA bound to the underivatized
MO show bands at the 150 bp range according to the ladder, because
the oligomers are approximately twice the mass and possess half the
charge. The result demonstrates that light exposure linearizes the <italic>gad1b</italic> MO, thereby facilitating its binding to the complementary
DNA, which served as a surrogate for the <italic>gad1</italic> mRNA.</p>
<fig id="sch4" position="float">
<label>Scheme 4</label>
<caption>
<title>Photolysis of ccMOs</title>
</caption>
<graphic id="gr5" position="float" xlink:href="cn-2018-00231t_0012" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig2" position="float">
<label>Figure 2</label>
<caption>
<p>Photoactivation of the <italic>gad1b</italic> MO from CyHQ-<italic>gad1b</italic>-ccMO <bold>4b-1</bold>. Results of gel shift assay
of MO hybridization to its complementary DNA: lane 1, DNA; lanes 2–4,
blank; lane 5, DNA and <italic>gad1b</italic> MO; lane 6, blank; lane
7, DNA, CyHQ-<italic>gad1b</italic>-ccMO, and light; lane 8, DNA,
CyHQ-<italic>gad1b</italic>-ccMO, no light; lane 9, blank; lane 10,
50 bp DNA ladder.</p>
</caption>
<graphic id="gr6" position="float" xlink:href="cn-2018-00231t_0002" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<p>An LC-MS/MS experiment
was used to quantify the time course of
photolysis of CyHQ-GAD1-ccMO (<bold>4b-1</bold>) at 405 nm (<xref ref-type="fig" rid="fig3">Figure <xref ref-type="fig" rid="fig3">3</xref></xref>), showing that the <italic>gad1b</italic> MO is activated rapidly with a quantum efficiency
of 0.36 (<xref ref-type="other" rid="tbl1">Table <xref ref-type="other" rid="tbl1">1</xref></xref>).
Quantitative evaluation of the photochemistry of BHQ-<italic>gad1b</italic>-ccMO (<bold>4a-1</bold>) was not performed because of its low molar
absorptivity in the 365–405 nm range of wavelengths. Experiments
in zebrafish (vide infra) show qualitatively photoactivation of <bold>4a-1</bold>. The photochemical properties of CyHQ-<italic>gad2</italic>-ccMO (<bold>4b-2</bold>) were not assessed because knocking down <italic>gad2</italic> does not cause craniofacial defects,<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> and the compound was not used in the zebrafish studies.
The <italic>gad1b</italic> and <italic>gad2</italic> MO sequences
differ substantially, demonstrating that a different MO sequence can
be coupled to the photocleaveable linker <bold>1b</bold> and supporting
the generality of the strategy for creating photactivatable MOs.</p>
<fig id="fig3" position="float">
<label>Figure 3</label>
<caption>
<p>Time course
of photolysis at 405 nm of CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) in water (50 μM). Each time point
is the average of two experiments, and error bars represent the range
of the measurement. Lines are least-squares fit of a simple decaying
exponential. HPLC trace of CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) before and after photolysis is shown in <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S3</ext-link>. Deconvoluted MS traces of CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) before and after light exposure
are shown in <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S4 and S5</ext-link>, respectively.</p>
</caption>
<graphic id="gr7" position="float" xlink:href="cn-2018-00231t_0003" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<table-wrap id="tbl1" position="float">
<label>Table 1</label>
<caption>
<title>Photophysical and
Photochemical Data
for ccMOs</title>
</caption>
<table border="0" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="×"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="center" style="border:none;"> </th>
<th align="center" char="." style="border:none;">λ<sub>max</sub> (nm)</th>
<th align="center" char="." style="border:none;">ε (M<sup>–1</sup> cm<sup>–1</sup>)</th>
<th align="center" char="." style="border:none;">ε<sub>405</sub> (M<sup>–1</sup> cm<sup>–1</sup>)</th>
<th align="center" char="." style="border:none;"><italic>t</italic><sub>90%</sub> s)</th>
<th align="center" char="×" style="border:none;"><italic>I</italic> (einstein cm<sup>–2</sup> s<sup>–1</sup>)<xref ref-type="table-fn" rid="t1fn1">a</xref></th>
<th align="center" char="." style="border:none;">
<italic>Q</italic>
<sub>u</sub>
<xref ref-type="table-fn" rid="t2fn1">a</xref>
</th>
<th align="center" char="." style="border:none;">sensitivity
(ε<italic>Q</italic><sub>u</sub>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="border:none;">
<bold>4a-1</bold>
</td>
<td align="char" char="." style="border:none;">265</td>
<td align="char" char="." style="border:none;">26 420</td>
<td align="char" char="." style="border:none;">460</td>
<td align="char" char="." style="border:none;"> </td>
<td align="char" char="×" style="border:none;"> </td>
<td align="char" char="." style="border:none;"> </td>
<td align="char" char="." style="border:none;"> </td>
</tr>
<tr>
<td align="left" style="border:none;">
<bold>4b-1</bold>
</td>
<td align="char" char="." style="border:none;">365</td>
<td align="char" char="." style="border:none;">26 580</td>
<td align="char" char="." style="border:none;">3160</td>
<td align="char" char="." style="border:none;">12.3</td>
<td align="char" char="×" style="border:none;">7.1 × 10<sup>–8</sup></td>
<td align="char" char="." style="border:none;">0.36</td>
<td align="char" char="." style="border:none;">1214</td>
</tr>
<tr>
<td align="left" style="border:none;">
<bold>4b-2</bold>
</td>
<td align="char" char="." style="border:none;">359</td>
<td align="char" char="." style="border:none;">26 550</td>
<td align="char" char="." style="border:none;">2650</td>
<td align="char" char="." style="border:none;"> </td>
<td align="char" char="×" style="border:none;"> </td>
<td align="char" char="." style="border:none;"> </td>
<td align="char" char="." style="border:none;"> </td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1fn1">
<label>a</label>
<p>Determined by potassium ferrioxalate
actinometry.</p>
</fn>
<fn id="t1fn2">
<label>b</label>
<p>Measured at
405 nm.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec2.3">
<title>Stability of ccMOs in the
Dark</title>
<p>CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>)
is relatively stable in the dark, having
a half-life of 11.1 days in Tris buffer (pH 7.2) (<xref ref-type="fig" rid="fig4">Figure <xref ref-type="fig" rid="fig4">4</xref></xref>). Under red light and room
light, the half-life decreases to 4.3 and 1.3 days, respectively.
Because ccMOs need to work in a living organism, they will be exposed
to degradative enzymes, so the stability of the ccMO, MO, and CyHQ-based
linker <bold>21</bold> (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Scheme S1</ext-link>) toward
enzymatic degradation in the dark by representative degradative enzymes
(proteinase K, Pronase E, esterase, and benzonase) was also evaluated
using an LC-MS/MS assay (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S6–S8</ext-link>). CyHQ-<italic>gad2</italic>-ccMO (<bold>4b-2</bold>) was used instead
of the <italic>gad1b</italic> version <bold>4b-1</bold>, to conserve
precious <italic>gad1b</italic> MO for biological studies. None of
the enzymes tested caused degradation of CyHQ-<italic>gad2</italic>-ccMO (<bold>4b-2</bold>) more rapidly than that caused by the reaction
buffers. Borate buffer (pH 8.0) was the most detrimental to <bold>4b-2</bold>. The ccMO was generally more stable than the <italic>gad2</italic> MO (<bold>2</bold>–<bold>2</bold>) and the pegylated
linker <bold>21</bold>. Given the similarity of the structures of <bold>4b-2</bold> and <bold>4b-1</bold>, it is reasonable to assume similar
stabilities.</p>
<fig id="fig4" position="float">
<label>Figure 4</label>
<caption>
<p>Time course of the degradation of CyHQ-<italic>gad1b</italic>-ccMO
(<bold>4b-1</bold>) in Tris buffer (pH 7.2) under three different
light conditions (dark, room light, and red light). Each time point
is the average of two experiments and error bars represent the range
of the measurement. Lines represent the least-squares fit of a single
exponential decay.</p>
</caption>
<graphic id="gr8" position="float" xlink:href="cn-2018-00231t_0004" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
</sec>
<sec id="sec2.4">
<title>CyHQ-gad1b-ccMO Enables
Bypass of Craniofacial Defects</title>
<p>Zebrafish embryos injected
at the 1–4 cell stage with <italic>gad1b</italic> MOs exhibited
morphological defects in head development
and outgrowth that were visible at 1 day post fertilization (dpf)
(<xref ref-type="fig" rid="fig5">Figure <xref ref-type="fig" rid="fig5">5</xref></xref>; <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S9</ext-link>). Changes visible by light microscopy
in live animals included altered distribution of the presumptive head
mesenchyme and altered gross structure of the midbrain-hindbrain region.
By 3 days of development, the <italic>gad1b</italic> morphant embryos
exhibited grossly normal brain structures, but exhibited aberrant
jaw morphologies (<xref ref-type="fig" rid="fig6">Figure <xref ref-type="fig" rid="fig6">6</xref></xref>). Assessment of the cartilaginous head skeleton by Alcian
blue staining in flat mount preparations at 7 dpf revealed defects
in both the neurocranium and the pharyngeal skeleton in <italic>gad1b</italic> morphant larvae (<xref ref-type="fig" rid="fig7">Figure <xref ref-type="fig" rid="fig7">7</xref></xref>; <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S10, S11, and S21</ext-link>). The
neurocranium includes the ethmoid plate, trabeculae and parachordal
cartilages, and the pharyngeal skeleton includes cartilages of the
segmented jaw, opercular, and gill-bearing skeleton.<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> Analysis of the neurocranium in <italic>gad1b</italic> morphants
revealed midline defects of the ethmoid plate and shortened trabeculae
(<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S10</ext-link>). Analysis of the pharyngeal
skeleton in <italic>gad1b</italic> morphants revealed midline defects
in Meckel’s cartilage and the basihyal cartilage; these structures
also exhibited altered cellular packing (<xref ref-type="fig" rid="fig7">Figure <xref ref-type="fig" rid="fig7">7</xref></xref>D,H; <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S10–S12, S21</ext-link>).</p>
<fig id="fig5" position="float">
<label>Figure 5</label>
<caption>
<p>Knockdown of Gad1 causes defects in head development and
outgrowth
visible at 1 dpf (A) wild-type; (B) <italic>gad1b</italic> splice
blocking MO; (C) <italic>gad1b</italic> translation blocking MO; (D,E)
BHQ-<italic>gad1b</italic>-ccMO; (F) <italic>gad1b</italic> mismatch
control for splice blocking MO; (G,H) CyHQ-<italic>gad1b</italic>-ccMO;
(I) <italic>gad1b</italic> mismatch control for translation blocking
MO. (D,G) BHQ- and CyHQ-<italic>gad1b</italic>-ccMO injected embryos
raised in the dark exhibit morphological development comparable to
wild-type embryos. (E, H) BHQ- and CyHQ-<italic>gad1b</italic>-ccMO
injected embryos raised in the light exhibit morphological development
comparable to embryos injected with <italic>gad1b</italic> splice
blocking or translation blocking MOs (B–C). Asterisk denotes
regions exhibiting altered distribution of the presumptive head mesenchyme;
bracket denotes altered gross structure of the midbrain-hindbrain
region. Normal development is observed in embryos injected with 5
base mismatch controls for the gad1b splice blocking MO (F) or translation
blocking MO (I). Scale bar in (A) applies to all panels. t, telencephalon;
e, eye; m, midbrain; h, hindbrain; o, otocyst.</p>
</caption>
<graphic id="gr9" position="float" xlink:href="cn-2018-00231t_0005" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig6" position="float">
<label>Figure 6</label>
<caption>
<p>Knockdown of Gad1 causes jaw defects visible at 3 dpf (A) wild-type;
(B) <italic>gad1b</italic> morphant; (C,D) BHQ-<italic>gad1</italic>b-ccMO; (E,F) CyHQ-<italic>gad1b</italic>-ccMO. (C,E) BHQ- and CyHQ-<italic>gad1b</italic>-ccMO injected embryos raised in the dark exhibit morphological
development comparable to wild-type embryos. (B, D, F). BHQ- and CyHQ-<italic>gad1b</italic>-ccMO injected embryos raised in the light exhibit
abnormal development of the presumptive lower jaw (region denoted
by bracket) comparable to embryos injected with <italic>gad1b</italic> MOs; region includes Meckel’s cartilage. Scale bar in (A)
applies to all panels.</p>
</caption>
<graphic id="gr10" position="float" xlink:href="cn-2018-00231t_0006" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig7" position="float">
<label>Figure 7</label>
<caption>
<p>Morphological development of craniofacial features in the developing
zebrafish probed by CyHQ-<italic>gad1b</italic>-ccMO. (A,B) Control
fish. (B) Alcian blue stained, flat mount preparation showing normal
development of Meckel’s (m), basihyal (bh), and palatoquadrate
(pq) cartilages. (C,D) The <italic>gad1b</italic> morphant fish exhibit
reduced Meckel’s and basihyal cartilages (denoted with brackets)
with midlines defects. Note irregular organization of the cells in
the Meckel’s cartilage of <italic>gad1b</italic> morphant fish
(asterisk in D and H) compared to controls or ccMO injected fish photoactivated
at 1 dpf.</p>
</caption>
<graphic id="gr11" position="float" xlink:href="cn-2018-00231t_0007" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<p>The observed morphological defects
were specific to <italic>gad1b</italic> MOs, and were observed using
translation-blocking (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures 5–7, S9–12, S21</ext-link>), splice-inhibiting
(<xref ref-type="fig" rid="fig5">Figures <xref ref-type="fig" rid="fig5">5</xref></xref> and <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">S21</ext-link>), and photocaged <italic>gad1b</italic> MOs
(<xref ref-type="fig" rid="fig5">Figures <xref ref-type="fig" rid="fig5">5</xref></xref>–<xref ref-type="fig" rid="fig7">7</xref>) that had been activated immediately after microinjection.
Normal development was observed in embryos in which <italic>gad1b</italic> translation-blocking MOs were coinjected with synthetic <italic>gad1b</italic> mRNA immune to the MO (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S9–S11, S27</ext-link>) or injected with <italic>gad1b</italic> mismatch MOs (<xref ref-type="fig" rid="fig5">Figures <xref ref-type="fig" rid="fig5">5</xref></xref> and <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">S21</ext-link>). Embryos injected with BHQ-<italic>gad1b</italic>-ccMO (<bold>4a-1</bold>) or CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) under red-light conditions and grown in
the dark exhibited grossly normal development (<xref ref-type="fig" rid="fig5">Figures <xref ref-type="fig" rid="fig5">5</xref></xref> and <xref ref-type="fig" rid="fig6">6</xref>) and exhibited
normal expression of neural crest markers in premigratory and early
migrating neural crest cells (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S24</ext-link>). Similarly, embryos injected with <italic>gad2</italic> translation-blocking
or splice-inhibiting MOs exhibited normal craniofacial development
(<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S9 and S12</ext-link>); however, <italic>gad2</italic> morphants exhibit altered neurological activity (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S26</ext-link>). Western blot analyses revealed that, in the absence
of synthetic mRNA, the MOs against <italic>gad1b</italic> and <italic>gad2</italic> were effective in reducing below the limit of detection
Gad proteins for the first 3–5 days of development (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S13–S20</ext-link>). These data suggest that
the <italic>gad1b</italic> MO perturbs normal craniofacial development.
Consistent with this, <italic>gad1b</italic> morphants exhibited altered
expression of early neural crest markers in the head region of embryos
just prior to the time of neural crest migration and in early migrating
neural crest cells (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S22 and S24</ext-link>),
and an altered distribution of presumptive migrating chondrogenic
neural crest cells in embryos at 1 dpf (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S23</ext-link>). The <italic>gad1b</italic> morphants at 1 dpf also exhibited
an increase in the number of apoptotic cells in the head and pharyngeal
arch regions as visualized by acridine orange staining in live embryos
(<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S23</ext-link>).</p>
<p>The craniofacial phenotype
in <italic>gad1b</italic> morphants
is surprising because genetic knockouts of <italic>gad1b</italic> do
not cause craniofacial defects (VanLeuven, A. J.; Ball, R. E.; Carpenter,
J. M.; Filipov, N. M.; Lauderdale, J. D., submitted). Given our careful
application of controls and rescue experiments following established
guidelines to help distinguish specific phenotypes from off-target
effects associated with MOs,<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> we conclude
that the <italic>gad1b</italic> MO-induced craniofacial phenotype
is due to perturbation of GABAergic signaling and represents a more
severe phenotype than in <italic>gad1b</italic> null mutants, as has
been observed with other MO-induced phenotypes compared to the corresponding
mutants.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> Consistent with this idea, treatment
of early stage embryos with GABA<sub>A</sub> receptor antagonists
alters expression of early neural crest markers in the head region
of embryos in a manner similar to that observed in <italic>gad1b</italic> morphants. One explanation is that the <italic>gad1b</italic> MO
is affecting expression of both <italic>gad1a</italic> and <italic>gad1b</italic>. Because they have similar mRNA sequences at the translation
start site,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> the <italic>gad1b</italic> MO may knockdown expression of both <italic>gad1a</italic> and <italic>gad1b</italic>. If this is the case, we hypothesize that zebrafish
embryos null for <italic>gad1a</italic> and <italic>gad1b</italic> will exhibit the craniofacially defective phenotype. Conversely,
the <italic>gad1b</italic> translation blocking MO is an exact match
for the sequence around the <italic>gad1b</italic> translation initiation
ATG (<xref ref-type="other" rid="tbl2">Table <xref ref-type="other" rid="tbl2">2</xref></xref>). When
compared to <italic>gad1a</italic>, the MO matches 19/25 nucleotides,
which would be expected to significantly reduce the binding affinity
with <italic>gad1a</italic>. Many studies make use of a five-base
mismatch control MO. A recent study investigating off-target effects
of MOs found that 11 consecutive bases complementary to a target sequence
were sufficient for binding and subsequent blocking of splice sites.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> The <italic>gad1b</italic> translation blocking
MO used in our study has only 8 consecutive bases complementary to <italic>gad1a</italic>, so it seems unlikely that the <italic>gad1b</italic> translation blocking MO used here would also block translation of <italic>gad1a</italic>. Nevetheless, this cannot be directly tested at this
time, because an antibody specific to Gad1a has yet to be identified.</p>
<table-wrap id="tbl2" position="float">
<label>Table 2</label>
<caption>
<title>Start Sequence Comparison between <italic>gad1a</italic>, <italic>gad1b</italic>, and the <italic>gad1b</italic> MO<xref ref-type="table-fn" rid="t2fn1">a</xref></title>
</caption>
<table border="0" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col/>
</colgroup>
<tbody>
<tr>
<td align="left" style="border:none;">
<italic>gad1b</italic>
</td>
<td align="left" style="border:none;">5′-GGACTG<bold>ATG</bold>GCGTCTTCTGCACCTT-3′</td>
<td align="left" style="border:none;">(25/25 match)</td>
</tr>
<tr>
<td align="left" style="border:none;"><italic>gad1b</italic> MO</td>
<td align="left" style="border:none;">3′-CCTGAC<underline>TAC</underline>CGCAGAAGACGTGGAA-5′</td>
<td align="left" style="border:none;"> </td>
</tr>
<tr>
<td align="left" style="border:none;">
<italic>gad1a</italic>
</td>
<td align="left" style="border:none;">5′-GaggTG<bold>ATG</bold>GCGgCgTCTGCACCcT-3′</td>
<td align="left" style="border:none;">(19/25 match)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t2fn1">
<label>a</label>
<p>Mismatched nucleotides
in <italic>gad1a</italic> compared to the <italic>gad1b</italic> MO
are denoted
in lower case. The start codons for <italic>gad1b</italic> and <italic>gad1a</italic> are denoted in bold.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Another explanation for the craniofacial phenotype
is that the <italic>gad1b MO</italic> alters isoform expression in
a developmentally
inappropriate way, and it is this change that leads to altered cartilage
development. We detected different isoforms of Gad1 protein in the
developing zebrafish, and the pattern of isoform expression changed
as a function of development (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S13</ext-link>). Interestingly, <italic>gad1b</italic> morphants exhibited a shift
in <italic>gad1</italic> isoform expression during the period when
the MO no longer fully suppressed translation (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S16</ext-link>). Although unexpected, this latter mechanism may
provide novel insight into <italic>gad</italic> gene function in non-neural
tissues.</p>
<p>To test if we could use photocaged ccMOs to knockdown <italic>gad1b</italic> activity while bypassing craniofacial deformities,
photoactivation
was carried out at 1 day of development. This time point was chosen
for two reasons. First, we hypothesized based on the head morphology
of <italic>gad1b</italic> morphants at 1 dpf that the defects in the
cartilages of the head skeleton were due to perturbation of the cranial
neural crest (CNC) cells either before or at the time that these cells
were migrating to populate the pharyngeal arches. Beginning at approximately
15 hpf, CNC cells delaminate from the ectoderm overlying the dorsal
neural tube in a wave originating at the midbrain and progress along
in caudal direction and migrate as separate streams into the pharyngeal
arches.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> The bulk of this migration occurs between
18 and 24 hpf. Neurocranial precursors originate in the midbrain region
and migrate between the eyes to form the palatal shelves, and the
pharyngeal arches are populated by CNCs that emigrate from the hindbrain.<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> Second, we wanted to knockdown <italic>gad1b</italic> activity in neurons in the developing brain and spinal cord. By
1 dpf, <italic>gad1b</italic> expressing neurons are detectable at
all axial levels of the CNS.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref64">64</xref>−<xref ref-type="bibr" rid="ref66">66</xref></sup></p>
<p>The hypothesis that <italic>gad1</italic> is expressed in
cranial
neural crest cells in zebrafish . Mice homozygous for mutations in <italic>GAD1</italic>, but not <italic>GAD2</italic>, or in the <italic>GABRB3</italic> subunit develop a cleft secondary palate.<sup><xref ref-type="bibr" rid="ref35">35</xref>−<xref ref-type="bibr" rid="ref38">38</xref></sup> Administration of GABA to GAD<sub>67</sub>-deficient mouse fetuses resulted in restoration of the first
steps of palate formation.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> In humans,
mutations in <italic>GABRB3</italic> and in the <italic>GAD1</italic> comes from human and mouse datatranscript unit have been linked
with nonsyndromic cleft lip with or without cleft palate.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> GABA produced by nonneuronal cells in the palatal epithelium mediates
cell proliferation during palatal shelf elevation and subsequently
cell migration and/or differentiation during palatal shelf fusion.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> During palatogenesis in mice, GAD and GABA are
expressed in the palatal epithelium of the vertical shelves, in the
medial edge epithelium of the horizontally oriented palatal shelves,
and in the epithelial seam during fusion.<sup><xref ref-type="bibr" rid="ref73">73</xref>−<xref ref-type="bibr" rid="ref75">75</xref></sup> Ubiquitous
expression of the GABA<sub>A</sub> β3 subunit gene rescued the
cleft palate in <italic>GABRB3</italic> mutant mice,<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> neuronal-specific transgene expression did not.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> In mice, too much GABA signaling<sup><xref ref-type="bibr" rid="ref77">77</xref>−<xref ref-type="bibr" rid="ref79">79</xref></sup> or too little<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> disrupts palate formation,
and a link between benzodiazepine (a potentiator of GABA signaling)
use during pregnancy and craniofacial defects has been reported in
humans,<sup><xref ref-type="bibr" rid="ref80">80</xref>−<xref ref-type="bibr" rid="ref82">82</xref></sup> but is controversial.<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> These data suggest the process during palatogenesis requires a specific
range of GABA signaling during a critical period for normal development;
however, the underlying cellular and molecular mechanism are not known.
Although secondary palate development does not appear to occur in
fish,<sup><xref ref-type="bibr" rid="ref84">84</xref>,<xref ref-type="bibr" rid="ref85">85</xref></sup> several lines of evidence are consistent
with the idea that GABAergic signaling (and Gad1) is playing a role
in the cranial neural crest. In addition to the knock-down data presented
(vide supra), treatment of embryos with pentylenetetrazole (PTZ),
a GABA<sub>A</sub> antagonist,<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> phenocopies
the increase in cells expressing neural crest markers in the brain
comparable to that observed in the morphants (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S25</ext-link>). The <italic>gad1b</italic> gene is expressed
in the early embryo as detected by RT-PCR (VanLeuven, A. J.; Ball,
R. E.; Gunderson, C. E.; Lauderdale, J. D., submitted).</p>
<p>Zebrafish
embryos were injected at the 1–4 cell stage with
CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) under red-light
conditions and raised in the dark for the first day of development.
Half the injected embryos were then photoactivated and returned to
the dark. All embryos were assessed for craniofacial development at
1, 3, and 7 dpf (<xref ref-type="fig" rid="fig7">Figure <xref ref-type="fig" rid="fig7">7</xref></xref>) and for behavioral and electrophysiological correlates of seizure
activity at 3 dpf (<xref ref-type="fig" rid="fig8">Figure <xref ref-type="fig" rid="fig8">8</xref></xref>). Zebrafish harboring the <italic>gad1b</italic> cMO activated
at 1 dpf exhibited normal or near-normal development of the cartilaginous
head skeleton (<xref ref-type="fig" rid="fig7">Figure <xref ref-type="fig" rid="fig7">7</xref></xref>), behavioral correlates of seizure (data not shown), and increased
and abnormal electrophysiological brain activity compared to wild
type animals (<xref ref-type="fig" rid="fig8">Figure <xref ref-type="fig" rid="fig8">8</xref></xref>), consistent with a reduction in GAD function. The electrophysiological
traces of the cMO morphants were comparable to those obtained from
larvae null for <italic>gad1b</italic> and wild-type fish exposed
to PTZ, which causes seizures in zebrafish.<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref88">88</xref></sup> PTZ acts by blocking the GABAergic systems, in particular inhibition
of GABA<sub>A</sub> receptor-mediated inhibitory postsynaptic potentials.<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> It has been widely used as a kindling model
of epilepsy in rodents<sup><xref ref-type="bibr" rid="ref89">89</xref></sup> that has recently
been extended to frogs and fish.<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref90">90</xref></sup> The differences
in the voltage amplitude between the recording from the <italic>gad1b</italic><sup>–/–</sup> fish (<xref ref-type="fig" rid="fig8">Figure <xref ref-type="fig" rid="fig8">8</xref></xref>D) and the CyHQ-GAD1-ccMO + light fish (<xref ref-type="fig" rid="fig8">Figure <xref ref-type="fig" rid="fig8">8</xref></xref>C) might reflect
the more severe effect of the MO.</p>
<fig id="fig8" position="float">
<label>Figure 8</label>
<caption>
<p>Zebrafish <italic>gad1b</italic> morphants
demonstrate abnormal
electrophysiological brain activity. Baseline electrophysiological
field recordings from the brain were made at 3 dpf on (A) wild-type
zebrafish, (B) fish grown in the dark from CyHQ-GAD1-ccMO (<bold>4b-1</bold>) injected embryos, (C) fish grown from CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) injected embryos and exposed to light at
1 dpf, (D) fish grown from <italic>gad1b</italic> null mutant embryos
(<italic>gad1b</italic><sup>–/–</sup>), and (E) wild-type
fish exposed to 15 mM pentylenetetrazole (PTZ).</p>
</caption>
<graphic id="gr12" position="float" xlink:href="cn-2018-00231t_0008" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
</sec>
</sec>
<sec id="sec3">
<title>Conclusions</title>
<p>Using a photocleavable linker, we prepared
BHQ- and CyHQ-based
ccMOs against <italic>gad1b</italic> and <italic>gad2</italic>. The
most efficiently photolyzed compound, CyHQ-<italic>gad1b</italic>-ccMO
(<bold>4b-1</bold>), had a quantum efficiency of 0.36 and was completely
linearized after a brief exposure to 405 nm light, thereby activating
it toward hybridization with its complementary <italic>gad1b</italic> mRNA partner. The ccMOs were sufficiently stable in the dark to
enable studies in zebrafish that last several days. Importantly, they
showed remarkable resistance to representative degradative enzymes
proteinase K, Pronase E, esterase, and benzonase. The high pH buffers
used in each of the assays were the sole cause of ccMO degradation;
the enzymes had no degradative effects on the ccMOs. Zebrafish embryos
injected with BHQ-<italic>gad1b</italic>-ccMO (<bold>4a-1</bold>)
or CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) and grown
in the dark developed normally, effectively bypassing the embryonically
lethal effect of knocking down <italic>gad1</italic> expression with
a <italic>gad1b</italic> MO, and enabling the observation of the abnormal
neurological effects of knocking down <italic>gad1b</italic> expression
in older animals. The photocleavable linker can be cyclized with any
MO, so this represents a general strategy for studying the role of
embryonically lethal genes at later stages of development in zebrafish.</p>
</sec>
<sec id="sec4">
<title>Methods</title>
<sec id="sec4.1">
<title>Genetic Nomenclature</title>
<p>Standard gene nomenclature is
used. For zebrafish, gene symbols are lowercase and italicized and
protein symbols are capitalized. For other vertebrates, human conventions
are used where gene symbols are in all capitals and italicized and
protein symbols are in all capitals. With respect to the full name
of the ccMOs, the gene symbol is formatted to be consistent with that
of the linker</p>
</sec>
<sec id="sec4.3">
<title>Synthesis</title>
<p>See the <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Supporting Information</ext-link> for detailed experimental procedures
to prepare BHQ linker <bold>1a</bold>, CyHQ linker <bold>1b</bold>, and CyHQ-linker-PEG <bold>21</bold>.</p>
<sec id="sec4.3.1">
<title>BHQ-gad1b-MO (<bold>3a-1</bold>), CyHQ-gad1b-MO (<bold>3b-1</bold>), and CyHQ-gad2-MO (<bold>3b-2</bold>)</title>
<p>A 25-base <italic>gad1</italic> or <italic>gad2</italic> MO oligomer with 5′-amine
and 3′-disulfide functionalization (<bold>2</bold>-<bold>1</bold>, 5′-AAGGTGCAGAAGACGCCATCAGTCC-3′,
or <bold>2</bold>-<bold>2</bold>, 5′-GAAACCAAAACCCGTGTGATGCCAT-3′;
50 or 100 nmol; Gene-Tools) was dissolved in 0.1 M Na<sub>2</sub>B<sub>4</sub>O<sub>7</sub>, pH 8.5 (100 μL). Photocleavable linker <bold>1a</bold> or <bold>1b</bold> (1.0 μmol, 67 equiv) in DMSO (15.0
μL) was added, and the reaction was shaken in the dark until
LC-MS indicated that it was complete. The resulting mixture was purified
on a NAP-5 gel-filtration column and lyophilized; the resulting white
solid was dissolved in water (200 μL). Acetic acid (2.00 μL)
was added to the solution, which was then washed successively with
chloroform (3 × 200 μL) and EtOAc (2 × 200 μL),
and then neutralized with 10% aq. NH<sub>4</sub>OH. The solution was
lyophilized to dryness, affording the conjugated product <bold>3a-1</bold>, <bold>3b-1</bold>, or <bold>3b-2</bold> as a white solid, which
was taken directly to the next step without further purification.
BHQ-<italic>gad1b</italic>-MO (<bold>3a-1</bold>): MS<bold>-</bold>ESI-LC-MS-Q-TOF (<italic>m</italic>/<italic>z</italic>) [M]<sup>+</sup> calcd for C<sub>349</sub>N<sub>165</sub>O<sub>106</sub>H<sub>534</sub>P<sub>25</sub>ClBrS<sub>2</sub> 9688, found 9688. CyHQ-<italic>gad1b</italic>-MO (<bold>3b-1</bold>): MS<bold>-</bold>ESI-LC-MS-Q-TOF (<italic>m</italic>/<italic>z</italic>) [M]<sup>+</sup> calcd for C<sub>342</sub>N<sub>166</sub>O<sub>106</sub>H<sub>524</sub>P<sub>25</sub>ClS<sub>2</sub>9531, found 9531. CyHQ-<italic>gad2</italic>-MO (<bold>3b-2</bold>): MS<bold>-</bold>ESI-LC-MS-Q-TOF (<italic>m</italic>/<italic>z</italic>) [M]<sup>+</sup> calcd for C<sub>342</sub>N<sub>163</sub>O<sub>106</sub>H<sub>525</sub>P<sub>25</sub>ClS<sub>2</sub>9490, found 9490.</p>
</sec>
<sec id="sec4.3.2">
<title>BHQ-gad1b-ccMO
(<bold>4a-1</bold>), CyHQ-gad1b-ccMO (<bold>4b-1</bold>), and CyHQ-gad2-ccMO
(<bold>4b-2</bold>)</title>
<p>Gel-immobilized
TCEP (100 μL) (Pierce Biotechnology) was washed with 0.1 M Tris-HCl
buffer, pH 8.4 (3 × 100 μL) in a centrifuge filter tube.
BHQ-GAD1MO (<bold>3a-1</bold>) or CyHQ-GAD1MO (<bold>3b-1</bold>)
was dissolved in 0.1 M Tris-HCl buffer, pH 8.4 (100 μL) and
added to the washed gel; the reaction was shaken for 10 h in the dark.
The supernatant was collected by centrifuge at 1000 rpm for 30 s.
The gel slurry was washed with 0.1 M Tris-HCl buffer, pH 8.4 (3 ×
100 μL), and the eluted fractions were combined with the supernatant.
This mixture was purified on a NAP-5 gel-filtration column and lyophilized
to afford <bold>4a-1</bold> (8.2 nmol, 17% over 2 steps), <bold>4b-1</bold> (35.1 nmol, 35% over 2 steps), or <bold>4b-2</bold> (29.0 nmol,
29% over 2 steps). BHQ-<italic>gad1b</italic>-ccMO (<bold>4a-1</bold>): MS<bold>-</bold>ESI-LC-MS-Q-TOF (<italic>m</italic>/<italic>z</italic>) [M]<sup>+</sup> calcd for C<sub>337</sub>N<sub>161</sub>O<sub>105</sub>H<sub>518</sub>P<sub>25</sub>BrS 9431,found 9433. CyHQ-<italic>gad1b</italic>-ccMO <italic>(</italic><bold><italic>4b-1</italic></bold><italic>)</italic>: MS<bold>-</bold>ESI-LC-MS-Q-TOF (<italic>m</italic>/<italic>z</italic>) [M]<sup>+</sup> calcd for C<sub>338</sub>N<sub>165</sub>O<sub>105</sub>H<sub>516</sub>P<sub>25</sub>S 9377, found 9376. CyHQ-<italic>gad2</italic>-ccMO (<bold>4b-2</bold>): MS<bold>-</bold>ESI-LC-MS-Q-TOF
(<italic>m</italic>/<italic>z</italic>) [M]<sup>+</sup> calcd for
C<sub>338</sub>N<sub>162</sub>O<sub>105</sub>H<sub>517</sub>P<sub>25</sub>S 9336, found 9336.</p>
</sec>
</sec>
<sec id="sec4.4">
<title>Photochemistry</title>
<sec id="sec4.4.1">
<title>Gel Shift
Assay</title>
<p>Solutions (0.88 μM) of nonderivatized
MO, its antisense DNA (5′-TTCCACGTCTTCTGCGGTAGTCAGG-3′),
irradiated ccMO (10 min exposure to light from a mercury lamp to achieve
complete photolysis), and nonirradiated ccMO were prepared in TBE
buffer. Light-sensitive materials were handled in the dark or under
red safety lamps. Four samples were prepared as follows: DNA solution
(8 μL), DNA solution (8 μL) and MO (8 μL), DNA solution
(8 μL) and photolyzed ccMO (8 μL), and unphotolyzed ccMO
(8 μL) and DNA solution (8 μL). Hybridization was performed
by heating the samples in a water bath (45 °C) for 30 min followed
by cooling on ice. Loading buffer (3 μL, 5×) was added
to each sample, which was subsequently loaded onto 12% native PAGE
gel. The gel was run with a 50 bp ladder (GelPilot, Qiagen) at 40
V for 3.5 h. Gels were stained with SYBR Gold nucleic acid gel stain
(Thermo Fisher Scientific) for 30 min for visualization.</p>
</sec>
<sec id="sec4.4.2">
<title>Quantum Efficiency</title>
<p>Compound <bold>1b</bold> was dissolved
in water, and an aqueous solution of <italic>gad1b</italic> MO (internal
standard) was added to a final concentration of 50 μM for both
analytes. Aliquots (50 μL) of the solution were placed in a
microcuvette (26.10F-Q-10, Starna, Atascadero, CA, 10 × 1 ×
1 mm<sup>3</sup> illuminated dimensions) and irradiated for different
time intervals (0, 5, 10, 20, 30, and 60 s) with a LED lamp (Cairn
OptoLED Lite) at 405 nm. Each time point was repeated in duplicate.
The irradiated solutions were analyzed by LC-MS/MS (Agilent UHD Accurate-Mass
QTOF LC/MS system 6540, Agilent Technologies, Palo Alto, CA) to quantify
the residual concentration of <bold>1b</bold>. Chromatographic profiles
were obtained using an Agilent PLRP-S C18 column 150 × 4.6 mm
with 8 μm particle size and gradient elution: eluent A being
acetonitrile and eluent B consisting of water. The analysis started
with 2% of eluent A, which was linearly increased up to 100% in 20
min, then remaining at 100% until 30 min. The flow rate was 0.5 mL
min<sup>–1</sup>, and injection volume was 10 μL. Quantification
of the eluted material was obtained by developing an appropriate MS-MS
method using the QTOF detector. Collision induced dissociation was
performed with a fixed collision energy set at 40 eV and two transitions
were recorded at <italic>m</italic>/<italic>z</italic> 1563.8 and
1849.5, operating the MSD in positive ion mode. Quantitative data
were obtained by comparison to standard calibration curves using the
Agilent MassHunter Workstation Software for Quantitative Analysis.
The percentages of compound left in solution were plotted versus time
of irradiation and fitted to a single exponential decay curve using
the software DeltaGraph (Red Rock Software, Inc.). The quantum efficiency
(<italic>Q</italic><sub>u</sub>) of the photolysis reaction was determined
as previously described,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> using the following
equation: <italic>Q</italic><sub>u</sub> = (<italic>I</italic>σ<italic>t</italic><sub>90%</sub>)<sup>−1</sup>,<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> where <italic>I</italic> is the intensity of the lamp in
einstein cm<sup>–2</sup> s<sup>–1</sup> (measured by
ferrioxalate actinometry<sup><xref ref-type="bibr" rid="ref92">92</xref></sup>), σ is
the decadic extinction coefficient (1000ε, molar extinction
coefficient), and <italic>t</italic><sub>90%</sub> is the time in
seconds required for 90% of the starting material to be photolyzed.</p>
</sec>
</sec>
<sec id="sec4.5">
<title>Stability Studies</title>
<sec id="sec4.5.1">
<title>Stability in the Dark, Red Light, and Room
Light</title>
<p>CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) was dissolved in Tris buffer
(150 mM KCl, 10 mM Tris-HCl, pH 7.2, phenol red 0.01%) to a final
concentration of 100 μM. Aliquots of the solution (50 μL)
were placed in microcentrifuge tubes and exposed to different light
conditions (dark, room white light, red light). The tubes were sampled
(6 μL) after different time intervals and aqueous solutions
of the internal standard (<italic>gad1b</italic> MO100 μM) were
added (6 μL) to a final concentration of 50 μM for both
analytes. Quantitative data were obtained with the same LC-MS/MS method
described for the photolysis experiment. The experiment was performed
in duplicate. The percentage of CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-1</bold>) remaining in solution was plotted against time and fitted
to a single exponential decay curve with the software DeltaGraph (Red
Rock Software Inc.). Three different curves were generated, representing
the three conditions evaluated (dark, room white light, red light).
Half-life (<italic>t</italic><sub>1/2</sub>) values were obtained
from the corresponding curve equation.</p>
</sec>
<sec id="sec4.5.2">
<title>Stability Toward Enzymatic
Degradation</title>
<p>CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-2</bold>) (3 nmol) was dissolved in
the appropriate buffer (<xref ref-type="other" rid="tbl3">Table <xref ref-type="other" rid="tbl3">3</xref></xref>) and a fresh solution of enzyme in buffer was added. Aliquots
of the resulting solution (50 μL) were placed in microcentrifuge
tubes and incubated at the appropriate temperature (<xref ref-type="other" rid="tbl3">Table <xref ref-type="other" rid="tbl3">3</xref></xref>) in the dark. A control experiment
without enzyme was also performed under the same conditions. The tubes
were sampled (10 μL) after different time intervals (0, 2, and
4 days) and combined with aqueous solutions of the internal standard
(<italic>gad2</italic> MO) (10 μL). Quantitative data were obtained
with the same LC-MS/MS method described for the photolysis experiments.
Each experiment was performed in triplicate. The same experimental
conditions were also used to evaluate the enzymatic stability of the
two separate portions of CyHQ-<italic>gad1b</italic>-ccMO (<bold>4b-2</bold>): the ad-hoc synthesized linker portion (CyHQ-linker-PEG, <bold>21</bold>) and the MO alone (<italic>gad2</italic> MO, <bold>2</bold>-<bold>2</bold>).</p>
<table-wrap id="tbl3" position="float">
<label>Table 3</label>
<caption>
<title>Experimental Conditions for the Enzymatic
Stability Experiment</title>
</caption>
<table border="0" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="center" style="border:none;">enzyme</th>
<th align="center" style="border:none;">buffer</th>
<th align="center" style="border:none;">enzyme concen</th>
<th align="center" style="border:none;">temperature</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="border:none;">proteinase K</td>
<td align="left" style="border:none;">Tris
50 mM, CaCl<sub>2</sub> 5 mM, pH 7.8</td>
<td align="left" style="border:none;">0.4 mg/mL (0.6 U/reaction)</td>
<td align="left" style="border:none;">37 °C</td>
</tr>
<tr>
<td align="left" style="border:none;">pronase E</td>
<td align="left" style="border:none;">Tris 50 mM, CaCl<sub>2</sub> 5 mM, pH 7.8</td>
<td align="left" style="border:none;">1.4 mg/mL (0.2 U/reaction)</td>
<td align="left" style="border:none;">37 °C</td>
</tr>
<tr>
<td align="left" style="border:none;">esterase</td>
<td align="left" style="border:none;">borate 10 mM, pH
8.0</td>
<td align="left" style="border:none;">3.3 mg/mL (2.5 U/reaction)</td>
<td align="left" style="border:none;">25 °C</td>
</tr>
<tr>
<td align="left" style="border:none;">benzonase</td>
<td align="left" style="border:none;">Tris 20 mM, MgCl<sub>2</sub> 2 mM, NaCl 20 mM, pH 8.0</td>
<td align="left" style="border:none;">0.5 μL (125 U/reaction)</td>
<td align="left" style="border:none;">37 °C</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>A positive control experiment was run in parallel
for each enzyme
to ensure that the hydrolase was active under the assay conditions.
The control substrate for the proteolytic and esterolytic enzymes
was <italic>N</italic>-acetyl-<sc>l</sc>-tyrosine ethyl ester (Ac-Tyr-OEt),
bearing both the ester and amide functionality. Almost complete hydrolysis
(&gt;90%) of Ac-Tyr-OEt was observed after 10 min of incubation in
all
cases (HPLC). An in-house DNA sequence was used as a positive control
for the benzonase stability experiment. Degradation of the DNA was
monitored by UV–vis spectroscopy (Δ<italic>A</italic><sub>265</sub>) with a NanoDrop spectrophotometer. A 50% increase
of absorptivity was found after 1 h of incubation with benzonase,
confirming DNA hydrolysis.</p>
</sec>
</sec>
<sec id="sec4.6">
<title>Zebrafish Studies</title>
<sec id="sec4.6.1">
<title>Zebrafish
Maintenance</title>
<p>Adult and larval zebrafish (<italic>Danio rerio</italic>) were obtained from lines maintained in the
University of Georgia Zebrafish Facility following standard procedures.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> Embryos and larvae were staged using standard
staging criteria.<sup><xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref></sup> Wild-type fish of the WIK strain
were originally obtained from the Zebrafish International Research
Center (ZIRC). The line of zebrafish mutant for <italic>gad1b</italic> was generated by CRISPR-Cas9 mediated genome editing of the <italic>gad1b</italic> locus. Additional details will be provided in a separate
publication (VanLeuven, A. J.; Ball, R. E.; Carpenter, J. M.; Filipov,
N. M.; Lauderdale, J. D., submitted). The <italic>gad1b</italic><sup>gav2303/gav2303</sup> allele used in these studies harbored a 10
bp deletion in exon 4 and was a functional null mutation. All adult
fish were maintained in an Aquatic Habitats (Apopka, FL) multirack
system. Habitat water consisted of reverse osmosis filtered/sterilized
water to which sodium bicarbonate and other salts (Instant Ocean,
Aquarium Systems, Inc., Mentor, OH) were added to maintain pH from
7.0 to 7.4 and conductivity between 400 and 430 μS. All experimental
procedures were conducted in accordance with National Institutes of
Health guidelines for use of zebrafish in research under protocols
approved and overseen by the University of Georgia Institutional Animal
Care and Use Committee.</p>
</sec>
<sec id="sec4.6.2">
<title>Morpholino Microinjection and mRNA Rescue</title>
<p>MOs were
microinjected using pressure into one to four-cell stage embryos following
standard protocols<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref96">96</xref></sup> under red-light conditions. Approximately
1 nL was injected into each embryo at the following concentrations: <italic>gad1</italic> MO, 0.3 ng/nL; <italic>gad2</italic> MO 1 ng/nL; BHQ-
or CyHQ-<italic>gad1</italic>-ccMO, 0.35–0.45 ng/nL. See <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figures S14–S17</ext-link> for titration data of <italic>gad1b</italic> and <italic>gad2</italic> MOs. The following 5 base
mismatch controls were used: <italic>gad1b</italic> translation blocking
mismatch MO, 5′-AAGCTCCAGAACACCCCATCACTCC-3′; <italic>gad2</italic> translation blocking mismatch MO 5′-GATAGCAAAAGCCGTCTCATGCCAT-3′.
In rescue experiments, a synthetic <italic>gad1b</italic> mRNA was
coinjected with the <italic>gad1b</italic> MO. The synthetic <italic>gad1b</italic> mRNA lacked the <italic>gad1b</italic> MO target sequence
while preserving the amino acid sequence; specifically, the sequence
was changed to 5′ GAA<bold>TTCACC</bold><underline>ATG</underline> GC<bold>A AGC AGC</bold> GC<bold>T</bold> CC<bold>A</bold> TCT...
where the nucleotides in bold were changed from the endogenous sequence
and the translation initiation site is underlined. See <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S22</ext-link> for titration data of synthetic <italic>gad1</italic> mRNA.</p>
</sec>
<sec id="sec4.6.3">
<title>Drugs</title>
<p>The pentylenetetrazol (PTZ)
used for this study
was purchased from Sigma-Aldrich (cat. #P6500, St. Louis, MO). Stock
PTZ solutions of 300 mM were prepared in distilled water following
protocols used for administration to mammals<sup><xref ref-type="bibr" rid="ref97">97</xref></sup> and stored in aliquots at −20 °C. Compounds dissolved
in embryo medium are readily absorbed through the gastrointestinal
tract or across the skin of larvae.<sup><xref ref-type="bibr" rid="ref98">98</xref></sup></p>
</sec>
<sec id="sec4.6.4">
<title>Electrophysiology</title>
<p>Electrophysiological recordings were
collected from 3 dpf zebrafish following protocols established for
7 dpf larvae.<sup><xref ref-type="bibr" rid="ref87">87</xref></sup> Briefly, zebrafish larvae
were immobilized by exposure to 250 μM α-bungarotoxin
(Life Technologies/ThermoFisher, cat. #B1601)<sup><xref ref-type="bibr" rid="ref99">99</xref></sup> in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl<sub>2</sub>,
0.33 mM MgSO<sub>4</sub>, pH 7.2)<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> and
mounted dorsal-side up in 1.2% agarose (Thermo Fisher Scientific,
Waltham, MA) in E3 medium. After embedding, larvae were placed on
the upright stage of a Zeiss Examiner.Z1 microscope (Carl Zeiss Microscopy,
LLC One Zeiss Drive Thornwood, NY 10594) and bathed with fresh E3
media. Under direct visual guidance, a glass microelectrode (approximately
1 μm tip diameter, 5–10 MΩ impedance) was placed
in the optic tectum. The optic tectum was chosen to facilitate comparison
with previously published data obtained from larval zebrafish.<sup><xref ref-type="bibr" rid="ref87">87</xref></sup> Electrodes were were filled with 2 M NaCl. A
chloride-coated silver wire (0.010 in., A-M Systems, Inc. Sequim,
WA) reference electrode was placed touching the medulla or spinal
cord. Field recordings were collected using an Axoclamp 900a amplifier
(Axon Instruments, Union City, CA). The amplified voltage was passed
through a Hum Bug Noise Eliminator (AutoMate Scientific, Berkley,
CA), band-pass filtered from 1 to 0.1 kHz, and digitized at 10 kHz
using a Digidata 1440 interface and stored on a PC using pClamp software
(version 10.3, Molecular Devices). Experiments were carried out at
23 ± 0.5 °C. To chemically induce seizures, larvae immobilized
in agar were exposed to E3 medium containing 15 mM PTZ, which is a
concentration shown to reliably induce clonus-like seizure behavior.<sup><xref ref-type="bibr" rid="ref87">87</xref></sup></p>
</sec>
<sec id="sec4.6.5">
<title>Western Blot Analysis</title>
<p>Western analysis
was performed
following standard protocols.<sup><xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref102">102</xref></sup> To determine MO knockdown
of <italic>gad</italic> gene encoded proteins, 30–100 embryos
per injection set were collected at 3 dpf, deyolked in ice-cold calcium-free
Ringer’s solution (116 mM NaCl, 2.9 mM KCl, 5.0 mM HEPES, pH
7.2),<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> and homogenized in a solution containing
60 100 μL RIPA buffer (cat. #89900, Thermo Fisher Scientific
Inc., Waltham, MA) with 1 mM EDTA solution and 1 mM protease inhibitor
cocktail (cat. #P8340, Sigma-Aldrich, St. Louis, MO). Samples were
centrifuged for 10 min at 18000<italic>g</italic> and the supernatant
collected and stored at −80 °C until further use. Protein
concentration was measured by Bradford assay.<sup><xref ref-type="bibr" rid="ref103">103</xref></sup> Samples containing 10 μg of total protein were separated
by SDS-PAGE and transferred to 0.45 μm nitrocellulose membrane
(Bio Rad, Hercules, CA). Blots were probed using a mouse monoclonal
to GAD<sub>67</sub> (cat. #sc-58531, Santa Cruz Biotechnology Inc.)
at a 1:200 dilution, a rabbit polyclonal to Gad2 (cat. #55772, AnaSpec,
Inc., Freemont, CA) at a 1:1000 dilution and a rabbit polyclonal to
GAPDH (ab9484, Abcam, Cambridge, MA) at a 1:10,000 dilution. Bands
were visualized by chemiluminescence (Immun-Star WesternC chemiluminescence
kit, Bio Rad, Hercules, CA).</p>
</sec>
<sec id="sec4.6.6">
<title>Alcian Blue Staining of
Cartilages</title>
<p>Cartilage staining
was performed using a modified protocol of Kimmel et al.<sup><xref ref-type="bibr" rid="ref104">104</xref></sup> Briefly, larvae were fixed in 4% PFA/PBS pH
7.0 at room temperature for 1 h. Larvae were washed three times in
70% ethanol (EtOH), and 30% hydrochloric acid (HCl) for 5 min. Larvae
were stained overnight in a solution of 0.1% alcian blue, 70% EtOH,
and 30% HCl. Samples were then differentiated in 70% EtOH and 30%
HCl until no blue color remained in the solution. For whole mount
analysis, depigmented larvae were stepwise rehydrated to water and
then cleared in a series of glycerol/1% KOH. For flat mount analysis,
larvae were stepwise rehydrated to water and then rinsed three times
in saturated sodium borate solution. Tissues were macerated in 3%
trypsin in equal volumes of water and sodium borate for 15–30
min. Cartilages were dissected out using fine forceps and samples
were rinsed in water before flat mounting.</p>
<p>Whole mount alcian
stains were mounted laterally and ventrally in 3% methylcellulose
in PBS and imaged on a Leica MZ FLIII fluorescent dissecting microscope
connected to a computer running Leica FireCam image capture software
(Leica Microsystems, Buffalo Grove, IL). Images were loaded into Adobe
PhotoShop (Adobe Systems Inc., San Jose, CA) and cartilage length
was measured for the bones that were not obstructed by tissue. Flat
mounted cartilages were digitally photographed using a Zeiss Axioscope
(Carl Zeiss Microscopy, LLC, One Zeiss Drive, Thornwood, NY 10594).
The Cell Counter plugin of ImageJ<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> was
used to analyze and count cells in flat mount cartilages.</p>
</sec>
</sec>
</sec>
</body>
<back>
<notes id="notes1" notes-type="si">
<title>Supporting Information Available</title>
<p>The Supporting Information is
available free of charge on the <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org" xmlns:xlink="http://www.w3.org/1999/xlink">ACS Publications website</ext-link> at DOI: <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acschemneuro.8b00231" xmlns:xlink="http://www.w3.org/1999/xlink">10.1021/acschemneuro.8b00231</ext-link>.<list id="silist" list-type="simple"><list-item><p>Preparation of
BHQ- and CyHQ-based linkers <bold>1a</bold> and <bold>1b</bold> and
CyHQ-linker-PEG (<bold>21</bold>), <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra, UV–vis spectra,
HPLC chromatograms, MS spectra; MO knockdown; enzymatic stability;
Western blot analysis (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschemneuro.8b00231/suppl_file/cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">PDF</ext-link>)</p></list-item></list></p>
</notes>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="sifile1">
<media xlink:href="cn8b00231_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>cn8b00231_si_001.pdf</p>
</caption>
</media>
</supplementary-material>
</sec>
<notes id="notes2" notes-type="">
<title>Author Contributions</title>
<p>M.J.O., L.L.B.,
D.D., R.E.B., A.T.P., A.J.V., K.T.H., S.P., and V.H. provided input
into experimental design, conducted the experiments, interpreted the
results, and assisted with writing the manuscript. M.J.O., L.L.B.,
and D.D. contributed equally. J.D.L. and T.M.D. conceived the overall
idea, designed the experiments, interpreted the results, and wrote
and edited the manuscript.</p>
</notes>
<notes id="notes3" notes-type="funding-statement">
<p>Supported by
Grants R01 NS070159 from the National Institutes of Health to T.M.D.
and J.D.L., R01 NS090645 from the National Institutes of Health to
J.D.L., CHE-1012412 and CHE-1317760 from the National Science Foundation
to T.M.D., and New York University Abu Dhabi.</p>
</notes>
<notes id="notes4" notes-type="COI-statement">
<p>The authors
declare no competing financial interest.</p>
</notes>
<ack>
<title>Acknowledgments</title>
<p>Lindsey McQuade, Ilya Shestopalov,
and James K.
Chen provided helpful advice. Part of the work was carried out using
Core Technology Platform resources at New York University Abu Dhabi
and mass spectrometry resources at the Proteomics and Mass Spectrometry
Core Facility at the University of Georgia.</p>
</ack>
<glossary id="dl1">
<def-list>
<title>Abbreviations</title>
<def-item>
<term>GAD1</term>
<def>
<p>glutamic acid decarboxylase 1</p>
</def>
</def-item>
<def-item>
<term>GAD2</term>
<def>
<p>glutamic acid
decarboxylase 2</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="ref1">
<mixed-citation id="cit1" publication-type="journal"><name><surname>Brooks-Kayal</surname><given-names>A. R.</given-names></name>; <name><surname>Raol</surname><given-names>Y. H.</given-names></name>; <name><surname>Russek</surname><given-names>S. J.</given-names></name> (<year>2009</year>) <article-title>Alteration of epileptogenesis genes</article-title>. <source/>Neurotherapeutics
<volume>6</volume>, <fpage>312</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.nurt.2009.01.019</pub-id>.<pub-id pub-id-type="pmid">19332325</pub-id></mixed-citation>
</ref>
<ref id="ref2">
<mixed-citation id="cit2" publication-type="journal"><name><surname>Hortopan</surname><given-names>G. A.</given-names></name>; <name><surname>Dinday</surname><given-names>M. T.</given-names></name>; <name><surname>Baraban</surname><given-names>S. C.</given-names></name> (<year>2010</year>) <article-title>Spontaneous seizures
and altered
gene expression in GABA signaling pathways in a mind bomb mutant zebrafish</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>13718</fpage>–<lpage>13728</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1887-10.2010</pub-id>.<pub-id pub-id-type="pmid">20943912</pub-id></mixed-citation>
</ref>
<ref id="ref3">
<mixed-citation id="cit3" publication-type="journal"><name><surname>Kash</surname><given-names>S. F.</given-names></name>; <name><surname>Johnson</surname><given-names>R. S.</given-names></name>; <name><surname>Tecott</surname><given-names>L. H.</given-names></name>; <name><surname>Noebels</surname><given-names>J. L.</given-names></name>; <name><surname>Mayfield</surname><given-names>R. D.</given-names></name>; <name><surname>Hanahan</surname><given-names>D.</given-names></name>; <name><surname>Baekkeskov</surname><given-names>S.</given-names></name> (<year>1997</year>) <article-title>Epilepsy in
mice deficient in the
65-kDa isoform of glutamic acid decarboxylase</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>94</volume>, <fpage>14060</fpage>–<lpage>14065</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.25.14060</pub-id>.<pub-id pub-id-type="pmid">9391152</pub-id></mixed-citation>
</ref>
<ref id="ref4">
<mixed-citation id="cit4" publication-type="journal"><name><surname>Akbarian</surname><given-names>S.</given-names></name>; <name><surname>Huang</surname><given-names>H.-S.</given-names></name> (<year>2006</year>) <article-title>Molecular and cellular
mechanisms of altered GAD1/GAD67
expression in schizophrenia and related disorders</article-title>. <source/>Brain Res. Rev.
<volume>52</volume>, <fpage>293</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2006.04.001</pub-id>.<pub-id pub-id-type="pmid">16759710</pub-id></mixed-citation>
</ref>
<ref id="ref5">
<mixed-citation id="cit5" publication-type="journal"><name><surname>Guidotti</surname><given-names>A.</given-names></name>; <name><surname>Auta</surname><given-names>J.</given-names></name>; <name><surname>Davis</surname><given-names>J. M.</given-names></name>; <name><surname>Gerevini</surname><given-names>V. D.</given-names></name>; <name><surname>Dwivedi</surname><given-names>Y.</given-names></name>; <name><surname>Grayson</surname><given-names>D. R.</given-names></name>; <name><surname>Impagnatiello</surname><given-names>F.</given-names></name>; <name><surname>Pandey</surname><given-names>G.</given-names></name>; <name><surname>Pesold</surname><given-names>C.</given-names></name>; <name><surname>Sharma</surname><given-names>R.</given-names></name>; <name><surname>Uzunov</surname><given-names>D.</given-names></name>; <name><surname>Costa</surname><given-names>E.</given-names></name> (<year>2000</year>) <article-title>Decrease in reelin
and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia
and bipolar disorder a postmortem brain study</article-title>. <source/>Arch. Gen. Psychiatry
<volume>57</volume>, <fpage>1061</fpage>–<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.11.1061</pub-id>.<pub-id pub-id-type="pmid">11074872</pub-id></mixed-citation>
</ref>
<ref id="ref6">
<mixed-citation id="cit6" publication-type="journal"><name><surname>Addington</surname><given-names>A. M.</given-names></name>; <name><surname>Gornick</surname><given-names>M.</given-names></name>; <name><surname>Duckworth</surname><given-names>J.</given-names></name>; <name><surname>Sporn</surname><given-names>A.</given-names></name>; <name><surname>Gogtay</surname><given-names>N.</given-names></name>; <name><surname>Bobb</surname><given-names>A.</given-names></name>; <name><surname>Greenstein</surname><given-names>D.</given-names></name>; <name><surname>Lenane</surname><given-names>M.</given-names></name>; <name><surname>Gochman</surname><given-names>P.</given-names></name>; <name><surname>Baker</surname><given-names>N.</given-names></name>; <name><surname>Balkissoon</surname><given-names>R.</given-names></name>; <name><surname>Vakkalanka</surname><given-names>R. K.</given-names></name>; <name><surname>Weinberger</surname><given-names>D. R.</given-names></name>; <name><surname>Rapoport</surname><given-names>J. L.</given-names></name>; <name><surname>Straub</surname><given-names>R. E.</given-names></name> (<year>2005</year>) <article-title>GAD1 (2q31.1),
which
encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset
schizophrenia and cortical gray matter volume loss</article-title>. <source/>Mol. Psychiatry
<volume>10</volume>, <fpage>581</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001599</pub-id>.<pub-id pub-id-type="pmid">15505639</pub-id></mixed-citation>
</ref>
<ref id="ref7">
<mixed-citation id="cit7" publication-type="journal"><name><surname>Hossein
Fatemi</surname><given-names>S.</given-names></name>; <name><surname>Stary</surname><given-names>J. M.</given-names></name>; <name><surname>Earle</surname><given-names>J. A.</given-names></name>; <name><surname>Araghi-Niknam</surname><given-names>M.</given-names></name>; <name><surname>Eagan</surname><given-names>E.</given-names></name> (<year>2005</year>) <article-title>GABAergic dysfunction in schizophrenia and mood disorders as reflected
by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and
Reelin proteins in cerebellum</article-title>. <source/>Schizophr. Res.
<volume>72</volume>, <fpage>109</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2004.02.017</pub-id>.<pub-id pub-id-type="pmid">15560956</pub-id></mixed-citation>
</ref>
<ref id="ref8">
<mixed-citation id="cit8" publication-type="journal"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name>; <name><surname>Halt</surname><given-names>A. R.</given-names></name>; <name><surname>Stary</surname><given-names>J. M.</given-names></name>; <name><surname>Kanodia</surname><given-names>R.</given-names></name>; <name><surname>Schulz</surname><given-names>S. C.</given-names></name>; <name><surname>Realmuto</surname><given-names>G. R.</given-names></name> (<year>2002</year>) <article-title>Glutamic acid decarboxylase
65 and 67 kDa proteins
are reduced in autistic parietal and cerebellar cortices</article-title>. <source/>Biol. Psychiatry
<volume>52</volume>, <fpage>805</fpage>–<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(02)01430-0</pub-id>.<pub-id pub-id-type="pmid">12372652</pub-id></mixed-citation>
</ref>
<ref id="ref9">
<mixed-citation id="cit9" publication-type="journal"><name><surname>Lynex</surname><given-names>C. N.</given-names></name>; <name><surname>Carr</surname><given-names>I. M.</given-names></name>; <name><surname>Leek</surname><given-names>J. P.</given-names></name>; <name><surname>Achuthan</surname><given-names>R.</given-names></name>; <name><surname>Mitchell</surname><given-names>S.</given-names></name>; <name><surname>Maher</surname><given-names>E. R.</given-names></name>; <name><surname>Woods</surname><given-names>C. G.</given-names></name>; <name><surname>Bonthon</surname><given-names>D. T.</given-names></name>; <name><surname>Markham</surname><given-names>A. F.</given-names></name> (<year>2004</year>) <article-title>Homozygosity
for a missense mutation in the 67 kDa isoform of glutamate decarboxylase
in a family with autosomal recessive spastic cerebral palsy: parallels
with Stiff-Person Syndrome and other movement disorders</article-title>. <source/>BMC Neurol.
<volume>4</volume>, <fpage>20</fpage><pub-id pub-id-type="doi">10.1186/1471-2377-4-20</pub-id>.<pub-id pub-id-type="pmid">15571623</pub-id></mixed-citation>
</ref>
<ref id="ref10">
<mixed-citation id="cit10" publication-type="journal"><name><surname>Levy</surname><given-names>L. M.</given-names></name>; <name><surname>Dalakas</surname><given-names>M. C.</given-names></name>; <name><surname>Floeter</surname><given-names>M. K.</given-names></name> (<year>1999</year>) <article-title>The stiff-person
syndrome: an autoimmune
disorder affecting neurotransmission of gamma-aminobutyric acid</article-title>. <source/>Ann. Intern. Med.
<volume>131</volume>, <fpage>522</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-131-7-199910050-00008</pub-id>.<pub-id pub-id-type="pmid">10507962</pub-id></mixed-citation>
</ref>
<ref id="ref11">
<mixed-citation id="cit11" publication-type="journal"><name><surname>Jessen</surname><given-names>K. R.</given-names></name>; <name><surname>Hills</surname><given-names>J. M.</given-names></name>; <name><surname>Saffrey</surname><given-names>M. J.</given-names></name> (<year>1986</year>) <article-title>Immunohistochemical
demonstration
of GABAergic neurons in the enteric nervous system</article-title>. <source/>J. Neurosci.
<volume>6</volume>, <fpage>1628</fpage>–<lpage>1634</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.06-06-01628.1986</pub-id>.<pub-id pub-id-type="pmid">3519888</pub-id></mixed-citation>
</ref>
<ref id="ref12">
<mixed-citation id="cit12" publication-type="journal"><name><surname>Bowery</surname><given-names>N. G.</given-names></name>; <name><surname>Doble</surname><given-names>A.</given-names></name>; <name><surname>Hill</surname><given-names>D. R.</given-names></name>; <name><surname>Hudson</surname><given-names>A. L.</given-names></name>; <name><surname>Shaw</surname><given-names>J. S.</given-names></name>; <name><surname>Turnbull</surname><given-names>M. J.</given-names></name>; <name><surname>Warrington</surname><given-names>R.</given-names></name> (<year>1981</year>) <article-title>Bicuculline-insensitive
GABA receptors
on peripheral autonomic nerve terminals</article-title>. <source/>Eur.
J. Pharmacol.
<volume>71</volume>, <fpage>53</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(81)90386-1</pub-id>.<pub-id pub-id-type="pmid">6263651</pub-id></mixed-citation>
</ref>
<ref id="ref13">
<mixed-citation id="cit13" publication-type="journal"><name><surname>Hill</surname><given-names>D. R.</given-names></name>; <name><surname>Bowery</surname><given-names>N. G.</given-names></name> (<year>1981</year>) <article-title>3H-baclofen and 3H-GABA bind to bicuculline-insensitive
GABA B sites in rat brain</article-title>. <source/>Nature
<volume>290</volume>, <fpage>149</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1038/290149a0</pub-id>.<pub-id pub-id-type="pmid">6259535</pub-id></mixed-citation>
</ref>
<ref id="ref14">
<mixed-citation id="cit14" publication-type="journal"><name><surname>Krantis</surname><given-names>A.</given-names></name> (<year>2000</year>) <article-title>GABA in the
mammalian enteric nervous system</article-title>. <source/>Physiology
<volume>15</volume>, <fpage>284</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1152/physiologyonline.2000.15.6.284</pub-id>.</mixed-citation>
</ref>
<ref id="ref15">
<mixed-citation id="cit15" publication-type="journal"><name><surname>Karlsen</surname><given-names>A. E.</given-names></name>; <name><surname>Hagopian</surname><given-names>W. A.</given-names></name>; <name><surname>Grubin</surname><given-names>C. E.</given-names></name>; <name><surname>Dube</surname><given-names>S.</given-names></name>; <name><surname>Disteche</surname><given-names>C. M.</given-names></name>; <name><surname>Adler</surname><given-names>D. A.</given-names></name>; <name><surname>Barmeier</surname><given-names>H.</given-names></name>; <name><surname>Mathewes</surname><given-names>S.</given-names></name>; <name><surname>Grant</surname><given-names>F. J.</given-names></name>; et al (<year>1991</year>) <article-title>Cloning and primary
structure of a human islet isoform
of glutamic acid decarboxylase from chromosome 10</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>88</volume>, <fpage>8337</fpage>–<lpage>8341</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.19.8337</pub-id>.<pub-id pub-id-type="pmid">1924293</pub-id></mixed-citation>
</ref>
<ref id="ref16">
<mixed-citation id="cit16" publication-type="journal"><name><surname>Rorsman</surname><given-names>P.</given-names></name>; <name><surname>Berggren</surname><given-names>P. O.</given-names></name>; <name><surname>Bokvist</surname><given-names>K.</given-names></name>; <name><surname>Ericson</surname><given-names>H.</given-names></name>; <name><surname>Moehler</surname><given-names>H.</given-names></name>; <name><surname>Oestenson</surname><given-names>C. G.</given-names></name>; <name><surname>Smith</surname><given-names>P. A.</given-names></name> (<year>1989</year>) <article-title>Glucose-inhibition of glucagon secretion
involves activation of GABAA-receptor chloride channels</article-title>. <source/>Nature
<volume>341</volume>, <fpage>233</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1038/341233a0</pub-id>.<pub-id pub-id-type="pmid">2550826</pub-id></mixed-citation>
</ref>
<ref id="ref17">
<mixed-citation id="cit17" publication-type="journal"><name><surname>Xiang</surname><given-names>Y.-Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Liu</surname><given-names>M.</given-names></name>; <name><surname>Hirota</surname><given-names>J. A.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Ju</surname><given-names>W.</given-names></name>; <name><surname>Fan</surname><given-names>Y.</given-names></name>; <name><surname>Kelly</surname><given-names>M. M.</given-names></name>; <name><surname>Ye</surname><given-names>B.</given-names></name>; <name><surname>Orser</surname><given-names>B.</given-names></name>; <name><surname>O’Byrne</surname><given-names>P. M.</given-names></name>; <name><surname>Inman</surname><given-names>M. D.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Lu</surname><given-names>W.-Y.</given-names></name> (<year>2007</year>) <article-title>A GABAergic
system in airway epithelium is essential for mucus overproduction
in asthma</article-title>. <source/>Nat. Med.
<volume>13</volume>, <fpage>862</fpage>–<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1038/nm1604</pub-id>.<pub-id pub-id-type="pmid">17589520</pub-id></mixed-citation>
</ref>
<ref id="ref18">
<mixed-citation id="cit18" publication-type="journal"><name><surname>Erdoe</surname><given-names>S. L.</given-names></name>; <name><surname>Wolff</surname><given-names>J. R.</given-names></name> (<year>1990</year>) <article-title>γ-Aminobutyric
acid outside the mammalian brain</article-title>. <source/>J. Neurochem.
<volume>54</volume>, <fpage>363</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1990.tb01882.x</pub-id>.<pub-id pub-id-type="pmid">2405103</pub-id></mixed-citation>
</ref>
<ref id="ref19">
<mixed-citation id="cit19" publication-type="journal"><name><surname>Baekkeskov</surname><given-names>S.</given-names></name>; <name><surname>Aanstoot</surname><given-names>H. J.</given-names></name>; <name><surname>Christgai</surname><given-names>S.</given-names></name>; <name><surname>Reetz</surname><given-names>A.</given-names></name>; <name><surname>Solimena</surname><given-names>M.</given-names></name>; <name><surname>Cascalho</surname><given-names>M.</given-names></name>; <name><surname>Folli</surname><given-names>F.</given-names></name>; <name><surname>Richter-Olesen</surname><given-names>H.</given-names></name>; <name><surname>Camilli</surname><given-names>P.-D.</given-names></name> (<year>1990</year>) <article-title>Identification of the 64K autoantigen
in insulin-dependent
diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase</article-title>. <source/>Nature
<volume>347</volume>, <fpage>151</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1038/347151a0</pub-id>.<pub-id pub-id-type="pmid">1697648</pub-id></mixed-citation>
</ref>
<ref id="ref20">
<mixed-citation id="cit20" publication-type="journal"><name><surname>Kaufman</surname><given-names>D. L.</given-names></name>; <name><surname>Erlander</surname><given-names>M. G.</given-names></name>; <name><surname>Clare-Salzler</surname><given-names>M.</given-names></name>; <name><surname>Atkinson</surname><given-names>M. A.</given-names></name>; <name><surname>Maclaren</surname><given-names>N. K.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name> (<year>1992</year>) <article-title>Autoimmunity to two forms of glutamate decarboxylase
in insulin-dependent diabetes mellitus</article-title>. <source/>J. Clin.
Invest.
<volume>89</volume>, <fpage>283</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1172/JCI115573</pub-id>.<pub-id pub-id-type="pmid">1370298</pub-id></mixed-citation>
</ref>
<ref id="ref21">
<mixed-citation id="cit21" publication-type="journal"><name><surname>Richter</surname><given-names>W.</given-names></name>; <name><surname>Endl</surname><given-names>J.</given-names></name>; <name><surname>Eiermann</surname><given-names>T. H.</given-names></name>; <name><surname>Brandt</surname><given-names>M.</given-names></name>; <name><surname>Kientsch-Engel</surname><given-names>R.</given-names></name>; <name><surname>Thivolet</surname><given-names>C.</given-names></name>; <name><surname>Jungfer</surname><given-names>H.</given-names></name>; <name><surname>Scherbaum</surname><given-names>W. A.</given-names></name> (<year>1992</year>) <article-title>Human monoclonal
islet cell antibodies from a patient with insulin-dependent diabetes
mellitus reveal glutamate decarboxylase as the target antigen</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>89</volume>, <fpage>8467</fpage>–<lpage>8471</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.18.8467</pub-id>.<pub-id pub-id-type="pmid">1382289</pub-id></mixed-citation>
</ref>
<ref id="ref22">
<mixed-citation id="cit22" publication-type="journal"><name><surname>Erlander</surname><given-names>M. G.</given-names></name>; <name><surname>Tillakaratne</surname><given-names>N. J. K.</given-names></name>; <name><surname>Feldblum</surname><given-names>S.</given-names></name>; <name><surname>Patel</surname><given-names>N.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name> (<year>1991</year>) <article-title>Two genes
encode distinct glutamate decarboxylases</article-title>. <source/>Neuron
<volume>7</volume>, <fpage>91</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(91)90077-D</pub-id>.<pub-id pub-id-type="pmid">2069816</pub-id></mixed-citation>
</ref>
<ref id="ref23">
<mixed-citation id="cit23" publication-type="journal"><name><surname>Erlander</surname><given-names>M. G.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name> (<year>1991</year>) <article-title>The structural and
functional heterogeneity of glutamic
acid decarboxylase: a review</article-title>. <source/>Neurochem. Res.
<volume>16</volume>, <fpage>215</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1007/BF00966084</pub-id>.<pub-id pub-id-type="pmid">1780024</pub-id></mixed-citation>
</ref>
<ref id="ref24">
<mixed-citation id="cit24" publication-type="journal"><name><surname>Legay</surname><given-names>F.</given-names></name>; <name><surname>Pelhate</surname><given-names>S.</given-names></name>; <name><surname>Tappaz</surname><given-names>M. L.</given-names></name> (<year>1986</year>) <article-title>Phylogenesis
of brain glutamic acid
decarboxylase from vertebrates: immunochemical studies</article-title>. <source/>J. Neurochem.
<volume>46</volume>, <fpage>1478</fpage>–<lpage>1486</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1986.tb01765.x</pub-id>.<pub-id pub-id-type="pmid">3083046</pub-id></mixed-citation>
</ref>
<ref id="ref25">
<mixed-citation id="cit25" publication-type="journal"><name><surname>Martin</surname><given-names>S. C.</given-names></name>; <name><surname>Heinrich</surname><given-names>G.</given-names></name>; <name><surname>Sandell</surname><given-names>J. H.</given-names></name> (<year>1998</year>) <article-title>Sequence
and expression of glutamic
acid decarboxylase isoforms in the developing zebrafish</article-title>. <source/>J. Comp. Neurol.
<volume>396</volume>, <fpage>253</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19980629)396:2&lt;253::AID-CNE9&gt;3.0.CO;2-#</pub-id>.<pub-id pub-id-type="pmid">9634146</pub-id></mixed-citation>
</ref>
<ref id="ref26">
<mixed-citation id="cit26" publication-type="journal"><name><surname>Martin</surname><given-names>D. L.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Martin</surname><given-names>S. B.</given-names></name>; <name><surname>Wu</surname><given-names>S. J.</given-names></name> (<year>2000</year>) <article-title>Structural features and regulatory
properties of the brain glutamate decarboxylases</article-title>. <source/>Neurochem. Int.
<volume>37</volume>, <fpage>111</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-0186(00)00014-0</pub-id>.<pub-id pub-id-type="pmid">10812196</pub-id></mixed-citation>
</ref>
<ref id="ref27">
<mixed-citation id="cit27" publication-type="journal"><name><surname>Kaufman</surname><given-names>D. L.</given-names></name>; <name><surname>Houser</surname><given-names>C. R.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name> (<year>1991</year>) <article-title>Two forms of the
γ-aminobutyric
acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal
distributions and cofactor interactions</article-title>. <source/>J.
Neurochem.
<volume>56</volume>, <fpage>720</fpage>–<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1991.tb08211.x</pub-id>.<pub-id pub-id-type="pmid">1988566</pub-id></mixed-citation>
</ref>
<ref id="ref28">
<mixed-citation id="cit28" publication-type="journal"><name><surname>Pinal</surname><given-names>C. S.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name> (<year>1998</year>) <article-title>Uniqueness and redundancy in GABA production</article-title>. <source/>Perspect. Dev. Neurobiol.
<volume>5</volume>, <fpage>109</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">9777629</pub-id></mixed-citation>
</ref>
<ref id="ref29">
<mixed-citation id="cit29" publication-type="journal"><name><surname>Esclapez</surname><given-names>M.</given-names></name>; <name><surname>Tillakaratne</surname><given-names>N. J. K.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name>; <name><surname>Houser</surname><given-names>C. R.</given-names></name> (<year>1993</year>) <article-title>Comparative localization
of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive
in situ hybridization methods</article-title>. <source/>J. Comp. Neurol.
<volume>331</volume>, <fpage>339</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903310305</pub-id>.<pub-id pub-id-type="pmid">8514913</pub-id></mixed-citation>
</ref>
<ref id="ref30">
<mixed-citation id="cit30" publication-type="journal"><name><surname>Feldblum</surname><given-names>S.</given-names></name>; <name><surname>Erlander</surname><given-names>M. G.</given-names></name>; <name><surname>Tobin</surname><given-names>A. J.</given-names></name> (<year>1993</year>) <article-title>Different
distributions of GAD65
and GAD67 mRNAs suggest that the two glutamate decarboxylases play
distinctive functional roles</article-title>. <source/>J. Neurosci. Res.
<volume>34</volume>, <fpage>689</fpage>–<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490340612</pub-id>.<pub-id pub-id-type="pmid">8315667</pub-id></mixed-citation>
</ref>
<ref id="ref31">
<mixed-citation id="cit31" publication-type="journal"><name><surname>Sheikh</surname><given-names>S. N.</given-names></name>; <name><surname>Martin</surname><given-names>S. B.</given-names></name>; <name><surname>Martin</surname><given-names>D. L.</given-names></name> (<year>1999</year>) <article-title>Regional
distribution and relative
amounts of glutamate decarboxylase isoforms in rat and mouse brain</article-title>. <source/>Neurochem. Int.
<volume>35</volume>, <fpage>73</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-0186(99)00063-7</pub-id>.<pub-id pub-id-type="pmid">10403432</pub-id></mixed-citation>
</ref>
<ref id="ref32">
<mixed-citation id="cit32" publication-type="journal"><name><surname>Cocco</surname><given-names>A.</given-names></name>; <name><surname>Roennberg</surname><given-names>A. M. C.</given-names></name>; <name><surname>Jin</surname><given-names>Z.</given-names></name>; <name><surname>Andre</surname><given-names>G. I.</given-names></name>; <name><surname>Vossen</surname><given-names>L. E.</given-names></name>; <name><surname>Bhandage</surname><given-names>A. K.</given-names></name>; <name><surname>Thoernqvist</surname><given-names>P.-O.</given-names></name>; <name><surname>Birnir</surname><given-names>B.</given-names></name>; <name><surname>Winberg</surname><given-names>S.</given-names></name> (<year>2017</year>) <article-title>Characterization
of the γ-aminobutyric acid signaling system in the zebrafish
(Danio rerio Hamilton) central nervous system by reverse transcription-quantitative
polymerase chain reaction</article-title>. <source/>Neuroscience
<volume>343</volume>, <fpage>300</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.07.018</pub-id>.<pub-id pub-id-type="pmid">27453477</pub-id></mixed-citation>
</ref>
<ref id="ref33">
<mixed-citation id="cit33" publication-type="journal"><name><surname>Varju</surname><given-names>P.</given-names></name>; <name><surname>Katarova</surname><given-names>Z.</given-names></name>; <name><surname>Madarasz</surname><given-names>E.</given-names></name>; <name><surname>Szabo</surname><given-names>G.</given-names></name> (<year>2001</year>) <article-title>GABA signalling during
development: new data and old questions</article-title>. <source/>Cell
Tissue Res.
<volume>305</volume>, <fpage>239</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1007/s004410100356</pub-id>.<pub-id pub-id-type="pmid">11545261</pub-id></mixed-citation>
</ref>
<ref id="ref34">
<mixed-citation id="cit34" publication-type="journal"><name><surname>Katarova</surname><given-names>Z.</given-names></name>; <name><surname>Sekerkova</surname><given-names>G.</given-names></name>; <name><surname>Prodan</surname><given-names>S.</given-names></name>; <name><surname>Mugnaini</surname><given-names>E.</given-names></name>; <name><surname>Szabo</surname><given-names>G.</given-names></name> (<year>2000</year>) <article-title>Domain-restricted
expression of two glutamic acid decarboxylase genes in midgestation
mouse embryos</article-title>. <source/>J. Comp. Neurol.
<volume>424</volume>, <fpage>607</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1002/1096-9861(20000904)424:4&lt;607::AID-CNE4&gt;3.0.CO;2-C</pub-id>.<pub-id pub-id-type="pmid">10931484</pub-id></mixed-citation>
</ref>
<ref id="ref35">
<mixed-citation id="cit35" publication-type="journal"><name><surname>Condie</surname><given-names>B. G.</given-names></name>; <name><surname>Bain</surname><given-names>G.</given-names></name>; <name><surname>Gottlieb</surname><given-names>D. I.</given-names></name>; <name><surname>Capecchi</surname><given-names>M. R.</given-names></name> (<year>1997</year>) <article-title>Cleft palate in
mice with a targeted mutation in the γ-aminobutyric acid-producing
enzyme glutamic acid decarboxylase 67</article-title>. <source/>Proc.
Natl. Acad. Sci. U. S. A.
<volume>94</volume>, <fpage>11451</fpage>–<lpage>11455</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.21.11451</pub-id>.<pub-id pub-id-type="pmid">9326630</pub-id></mixed-citation>
</ref>
<ref id="ref36">
<mixed-citation id="cit36" publication-type="journal"><name><surname>Asada</surname><given-names>H.</given-names></name>; <name><surname>Kawamura</surname><given-names>Y.</given-names></name>; <name><surname>Maruyama</surname><given-names>K.</given-names></name>; <name><surname>Kume</surname><given-names>H.</given-names></name>; <name><surname>Ding</surname><given-names>R.-G.</given-names></name>; <name><surname>Kanbara</surname><given-names>N.</given-names></name>; <name><surname>Kuzume</surname><given-names>H.</given-names></name>; <name><surname>Sanbo</surname><given-names>M.</given-names></name>; <name><surname>Yagi</surname><given-names>T.</given-names></name>; <name><surname>Obata</surname><given-names>K.</given-names></name> (<year>1997</year>) <article-title>Cleft palate and decreased brain
γ-aminobutyric acid in mice
lacking the 67-kDa isoform of glutamic acid decarboxylase</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>94</volume>, <fpage>6496</fpage>–<lpage>6499</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.12.6496</pub-id>.<pub-id pub-id-type="pmid">9177246</pub-id></mixed-citation>
</ref>
<ref id="ref37">
<mixed-citation id="cit37" publication-type="journal"><name><surname>Culiat</surname><given-names>C. T.</given-names></name>; <name><surname>Stubbs</surname><given-names>L. J.</given-names></name>; <name><surname>Woychik</surname><given-names>R. P.</given-names></name>; <name><surname>Russell</surname><given-names>L. B.</given-names></name>; <name><surname>Johnson</surname><given-names>D. K.</given-names></name>; <name><surname>Rinchik</surname><given-names>E. M.</given-names></name> (<year>1995</year>) <article-title>Deficiency of the
β3 subunit of the type A γ-aminobutyric
acid receptor causes cleft palate in mice</article-title>. <source/>Nat.
Genet.
<volume>11</volume>, <fpage>344</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1038/ng1195-344</pub-id>.<pub-id pub-id-type="pmid">7581464</pub-id></mixed-citation>
</ref>
<ref id="ref38">
<mixed-citation id="cit38" publication-type="journal"><name><surname>Homanics</surname><given-names>G.
E.</given-names></name>; <name><surname>DeLorey</surname><given-names>T. M.</given-names></name>; <name><surname>Firestone</surname><given-names>L. L.</given-names></name>; <name><surname>Quinlan</surname><given-names>J. J.</given-names></name>; <name><surname>Handforth</surname><given-names>A.</given-names></name>; <name><surname>Harrison</surname><given-names>N. L.</given-names></name>; <name><surname>Krasowski</surname><given-names>M. D.</given-names></name>; <name><surname>Rick</surname><given-names>C. E.</given-names></name>; <name><surname>Korpi</surname><given-names>E. R.</given-names></name>; <name><surname>Makela</surname><given-names>R.</given-names></name>; <name><surname>Brilliant</surname><given-names>M. H.</given-names></name>; <name><surname>Hagiwara</surname><given-names>N.</given-names></name>; <name><surname>Ferguson</surname><given-names>C.</given-names></name>; <name><surname>Snyder</surname><given-names>K.</given-names></name>; <name><surname>Olsen</surname><given-names>R. W.</given-names></name> (<year>1997</year>) <article-title>Mice devoid of gamma-aminobutyrate
type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive
behavior</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>94</volume>, <fpage>4143</fpage>–<lpage>4148</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.8.4143</pub-id>.<pub-id pub-id-type="pmid">9108119</pub-id></mixed-citation>
</ref>
<ref id="ref39">
<mixed-citation id="cit39" publication-type="journal"><name><surname>Kanno</surname><given-names>K.</given-names></name>; <name><surname>Suzuki</surname><given-names>Y.</given-names></name>; <name><surname>Yamada</surname><given-names>A.</given-names></name>; <name><surname>Aoki</surname><given-names>Y.</given-names></name>; <name><surname>Kure</surname><given-names>S.</given-names></name>; <name><surname>Matsubara</surname><given-names>Y.</given-names></name> (<year>2004</year>) <article-title>Association
between nonsyndromic cleft lip with or
without cleft palate and the glutamic acid decarboxylase 67 gene in
the Japanese population</article-title>. <source/>Am. J. Med. Genet.
<volume>127A</volume>, <fpage>11</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.20649</pub-id>.<pub-id pub-id-type="pmid">15103710</pub-id></mixed-citation>
</ref>
<ref id="ref40">
<mixed-citation id="cit40" publication-type="journal"><name><surname>Scapoli</surname><given-names>L.</given-names></name>; <name><surname>Martinelli</surname><given-names>M.</given-names></name>; <name><surname>Pezzetti</surname><given-names>F.</given-names></name>; <name><surname>Carinci</surname><given-names>F.</given-names></name>; <name><surname>Bodo</surname><given-names>M.</given-names></name>; <name><surname>Tognon</surname><given-names>M.</given-names></name>; <name><surname>Carinci</surname><given-names>P.</given-names></name> (<year>2002</year>) <article-title>Linkage disequilibrium between GABRB3
gene and nonsyndromic familial cleft lip with or without cleft palate</article-title>. <source/>Hum. Genet.
<volume>110</volume>, <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-001-0639-5</pub-id>.<pub-id pub-id-type="pmid">11810291</pub-id></mixed-citation>
</ref>
<ref id="ref41">
<mixed-citation id="cit41" publication-type="journal"><name><surname>Deiters</surname><given-names>A.</given-names></name>; <name><surname>Yoder</surname><given-names>J. A.</given-names></name> (<year>2006</year>) <article-title>Conditional Transgene and Gene Targeting
Methodologies
in Zebrafish</article-title>. <source/>Zebrafish
<volume>3</volume>, <fpage>415</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1089/zeb.2006.3.415</pub-id>.<pub-id pub-id-type="pmid">18377222</pub-id></mixed-citation>
</ref>
<ref id="ref42">
<mixed-citation id="cit42" publication-type="journal"><name><surname>Esengil</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name> (<year>2008</year>) <article-title>Gene regulation
technologies in zebrafish</article-title>. <source/>Mol. BioSyst.
<volume>4</volume>, <fpage>300</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1039/b718447f</pub-id>.<pub-id pub-id-type="pmid">18354783</pub-id></mixed-citation>
</ref>
<ref id="ref43">
<mixed-citation id="cit43" publication-type="journal"><name><surname>Shestopalov</surname><given-names>I. A.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name> (<year>2008</year>) <article-title>Chemical technologies
for probing embryonic development</article-title>. <source/>Chem. Soc.
Rev.
<volume>37</volume>, <fpage>1294</fpage>–<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1039/b703023c</pub-id>.<pub-id pub-id-type="pmid">18568156</pub-id></mixed-citation>
</ref>
<ref id="ref44">
<mixed-citation id="cit44" publication-type="journal"><name><surname>Nasevicius</surname><given-names>A.</given-names></name>; <name><surname>Ekker</surname><given-names>S. C.</given-names></name> (<year>2000</year>) <article-title>Effective
targeted gene “knockdown” in
zebrafish</article-title>. <source/>Nat. Genet.
<volume>26</volume>, <fpage>216</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/79951</pub-id>.<pub-id pub-id-type="pmid">11017081</pub-id></mixed-citation>
</ref>
<ref id="ref45">
<mixed-citation id="cit45" publication-type="journal"><name><surname>Skromne</surname><given-names>I.</given-names></name>; <name><surname>Prince</surname><given-names>V. E.</given-names></name> (<year>2008</year>) <article-title>Current perspectives
in zebrafish reverse genetics:
moving forward</article-title>. <source/>Dev. Dyn.
<volume>237</volume>, <fpage>861</fpage>–<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.21484</pub-id>.<pub-id pub-id-type="pmid">18330930</pub-id></mixed-citation>
</ref>
<ref id="ref46">
<mixed-citation id="cit46" publication-type="journal"><name><surname>Tang</surname><given-names>X.</given-names></name>; <name><surname>Maegawa</surname><given-names>S.</given-names></name>; <name><surname>Weinberg</surname><given-names>E. S.</given-names></name>; <name><surname>Dmochowski</surname><given-names>I. J.</given-names></name> (<year>2007</year>) <article-title>Regulating
gene expression in zebrafish embryos using light-activated, negatively
charged peptide nucleic acids</article-title>. <source/>J. Am. Chem.
Soc.
<volume>129</volume>, <fpage>11000</fpage>–<lpage>11001</lpage>. <pub-id pub-id-type="doi">10.1021/ja073723s</pub-id>.<pub-id pub-id-type="pmid">17711280</pub-id></mixed-citation>
</ref>
<ref id="ref47">
<mixed-citation id="cit47" publication-type="journal"><name><surname>Dmochowski</surname><given-names>I. J.</given-names></name>; <name><surname>Tang</surname><given-names>X.</given-names></name> (<year>2007</year>) <article-title>Taking control
of gene expression with light-activated oligonucleotides</article-title>. <source/>BioTechniques
<volume>43</volume>, <fpage>161</fpage><pub-id pub-id-type="doi">10.2144/000112519</pub-id>.<pub-id pub-id-type="pmid">17824383</pub-id></mixed-citation>
<note>
<p>163,165,167,169,171</p>
</note>
</ref>
<ref id="ref48">
<mixed-citation id="cit48" publication-type="journal"><name><surname>Tang</surname><given-names>X.</given-names></name>; <name><surname>Dmochowski</surname><given-names>I. J.</given-names></name> (<year>2007</year>) <article-title>Regulating gene expression with light-activated
oligonucleotides</article-title>. <source/>Mol. BioSyst.
<volume>3</volume>, <fpage>100</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1039/B614349K</pub-id>.<pub-id pub-id-type="pmid">17245489</pub-id></mixed-citation>
</ref>
<ref id="ref49">
<mixed-citation id="cit49" publication-type="journal"><name><surname>Tang</surname><given-names>X.</given-names></name>; <name><surname>Dmochowski</surname><given-names>I. J.</given-names></name> (<year>2006</year>) <article-title>Controlling
RNA digestion by RNase H with a light-activated
DNA hairpin</article-title>. <source/>Angew. Chem., Int. Ed.
<volume>45</volume>, <fpage>3523</fpage>–<lpage>3526</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200600954</pub-id>.</mixed-citation>
</ref>
<ref id="ref50">
<mixed-citation id="cit50" publication-type="journal"><name><surname>Shestopalov</surname><given-names>I. A.</given-names></name>; <name><surname>Sinha</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name> (<year>2007</year>) <article-title>Light-controlled
gene silencing in
zebrafish embryos</article-title>. <source/>Nat. Chem. Biol.
<volume>3</volume>, <fpage>650</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2007.30</pub-id>.<pub-id pub-id-type="pmid">17717538</pub-id></mixed-citation>
</ref>
<ref id="ref51">
<mixed-citation id="cit51" publication-type="journal"><name><surname>Ouyang</surname><given-names>X.</given-names></name>; <name><surname>Shestopalov</surname><given-names>I. A.</given-names></name>; <name><surname>Sinha</surname><given-names>S.</given-names></name>; <name><surname>Zheng</surname><given-names>G.</given-names></name>; <name><surname>Pitt</surname><given-names>C. L. W.</given-names></name>; <name><surname>Li</surname><given-names>W.-H.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name> (<year>2009</year>) <article-title>Versatile Synthesis
and Rational Design of Caged Morpholinos</article-title>. <source/>J.
Am. Chem. Soc.
<volume>131</volume>, <fpage>13255</fpage>–<lpage>13269</lpage>. <pub-id pub-id-type="doi">10.1021/ja809933h</pub-id>.<pub-id pub-id-type="pmid">19708646</pub-id></mixed-citation>
</ref>
<ref id="ref52">
<mixed-citation id="cit52" publication-type="journal"><name><surname>Fedoryak</surname><given-names>O. D.</given-names></name>; <name><surname>Dore</surname><given-names>T. M.</given-names></name> (<year>2002</year>) <article-title>Brominated hydroxyquinoline as a photolabile protecting
group with sensitivity to multiphoton excitation</article-title>. <source/>Org. Lett.
<volume>4</volume>, <fpage>3419</fpage>–<lpage>3422</lpage>. <pub-id pub-id-type="doi">10.1021/ol026524g</pub-id>.<pub-id pub-id-type="pmid">12323033</pub-id></mixed-citation>
</ref>
<ref id="ref53">
<mixed-citation id="cit53" publication-type="journal"><name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Pavlos</surname><given-names>C. M.</given-names></name>; <name><surname>Toscano</surname><given-names>J. P.</given-names></name>; <name><surname>Dore</surname><given-names>T. M.</given-names></name> (<year>2006</year>) <article-title>8-Bromo-7-hydroxyquinoline
as a Photoremovable Protecting Group for Physiological Use: Mechanism
and Scope</article-title>. <source/>J. Am. Chem. Soc.
<volume>128</volume>, <fpage>4267</fpage>–<lpage>4276</lpage>. <pub-id pub-id-type="doi">10.1021/ja0555320</pub-id>.<pub-id pub-id-type="pmid">16569001</pub-id></mixed-citation>
</ref>
<ref id="ref54">
<mixed-citation id="cit54" publication-type="journal"><name><surname>Tomasini</surname><given-names>A. J.</given-names></name>; <name><surname>Schuler</surname><given-names>A. D.</given-names></name>; <name><surname>Zebala</surname><given-names>J. A.</given-names></name>; <name><surname>Mayer</surname><given-names>A. N.</given-names></name> (<year>2009</year>) <article-title>PhotoMorphs: a novel
light-activated reagent for controlling gene expression in zebrafish</article-title>. <source/>Genesis
<volume>47</volume>, <fpage>736</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1002/dvg.20554</pub-id>.<pub-id pub-id-type="pmid">19644983</pub-id></mixed-citation>
</ref>
<ref id="ref55">
<mixed-citation id="cit55" publication-type="journal"><name><surname>Tallafuss</surname><given-names>A.</given-names></name>; <name><surname>Gibson</surname><given-names>D.</given-names></name>; <name><surname>Morcos</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Seredick</surname><given-names>S.</given-names></name>; <name><surname>Eisen</surname><given-names>J.</given-names></name>; <name><surname>Washbourne</surname><given-names>P.</given-names></name> (<year>2012</year>) <article-title>Turning gene function ON and OFF
using sense and antisense photo-morpholinos in zebrafish</article-title>. <source/>Development
<volume>139</volume>, <fpage>1691</fpage>–<lpage>1699</lpage>. <pub-id pub-id-type="doi">10.1242/dev.072702</pub-id>.<pub-id pub-id-type="pmid">22492359</pub-id></mixed-citation>
</ref>
<ref id="ref56">
<mixed-citation id="cit56" publication-type="journal"><name><surname>Deiters</surname><given-names>A.</given-names></name>; <name><surname>Garner</surname><given-names>R. A.</given-names></name>; <name><surname>Lusic</surname><given-names>H.</given-names></name>; <name><surname>Govan</surname><given-names>J. M.</given-names></name>; <name><surname>Dush</surname><given-names>M.</given-names></name>; <name><surname>Nascone-Yoder</surname><given-names>N. M.</given-names></name>; <name><surname>Yoder</surname><given-names>J. A.</given-names></name> (<year>2010</year>) <article-title>Photocaged Morpholino Oligomers for
the Light-Regulation of Gene Function in Zebrafish and Xenopus Embryos</article-title>. <source/>J. Am. Chem. Soc.
<volume>132</volume>, <fpage>15644</fpage>–<lpage>15650</lpage>. <pub-id pub-id-type="doi">10.1021/ja1053863</pub-id>.<pub-id pub-id-type="pmid">20961123</pub-id></mixed-citation>
</ref>
<ref id="ref57">
<mixed-citation id="cit57" publication-type="journal"><name><surname>Yamazoe</surname><given-names>S.</given-names></name>; <name><surname>Shestopalov</surname><given-names>I. A.</given-names></name>; <name><surname>Provost</surname><given-names>E.</given-names></name>; <name><surname>Leach</surname><given-names>S. D.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name> (<year>2012</year>) <article-title>Cyclic
caged morpholinos: conformationally gated probes of embryonic gene
function</article-title>. <source/>Angew. Chem., Int. Ed.
<volume>51</volume>, <fpage>6908</fpage>–<lpage>6911</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201201690</pub-id>.</mixed-citation>
</ref>
<ref id="ref58">
<mixed-citation id="cit58" publication-type="journal"><name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>P.</given-names></name>; <name><surname>Lv</surname><given-names>C.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Tang</surname><given-names>X.</given-names></name> (<year>2012</year>) <article-title>Manipulation
of gene expression in zebrafish using caged circular morpholino oligomers</article-title>. <source/>Nucleic Acids Res.
<volume>40</volume>, <fpage>11155</fpage>–<lpage>11162</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks840</pub-id>.<pub-id pub-id-type="pmid">23002141</pub-id></mixed-citation>
</ref>
<ref id="ref59">
<mixed-citation id="cit59" publication-type="journal"><name><surname>Yamazoe</surname><given-names>S.</given-names></name>; <name><surname>Liu</surname><given-names>Q.</given-names></name>; <name><surname>McQuade</surname><given-names>L. E.</given-names></name>; <name><surname>Deiters</surname><given-names>A.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name> (<year>2014</year>) <article-title>Sequential gene
silencing using wavelength-selective caged morpholino oligonucleotides</article-title>. <source/>Angew. Chem., Int. Ed.
<volume>53</volume>, <fpage>10114</fpage>–<lpage>10118</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201405355</pub-id>.</mixed-citation>
</ref>
<ref id="ref106">
<mixed-citation id="cit106" publication-type="journal"><name><surname>Griepenburg</surname><given-names>J. C.</given-names></name>; <name><surname>Rapp</surname><given-names>T. L.</given-names></name>; <name><surname>Carroll</surname><given-names>P. J.</given-names></name>; <name><surname>Eberwine</surname><given-names>J.</given-names></name>; <name><surname>Dmochowski</surname><given-names>I. J.</given-names></name> (<year>2015</year>) <article-title>Ruthenium-caged antisense morpholinos for regulating
gene expression in zebrafish embryos</article-title>. <source/>Chem.
Sci.
<volume>6</volume>, <fpage>2342</fpage>–<lpage>2346</lpage>.<pub-id pub-id-type="pmid">26023327</pub-id></mixed-citation>
</ref>
<ref id="ref60">
<mixed-citation id="cit60" publication-type="journal"><name><surname>Davis</surname><given-names>M. J.</given-names></name>; <name><surname>Kragor</surname><given-names>C. H.</given-names></name>; <name><surname>Reddie</surname><given-names>K. G.</given-names></name>; <name><surname>Wilson</surname><given-names>H. C.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Dore</surname><given-names>T. M.</given-names></name> (<year>2009</year>) <article-title>Substituent Effects
on the Sensitivity of a Quinoline
Photoremovable Protecting Group to One- and Two-Photon Excitation</article-title>. <source/>J. Org. Chem.
<volume>74</volume>, <fpage>1721</fpage>–<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.1021/jo802658a</pub-id>.<pub-id pub-id-type="pmid">19140722</pub-id></mixed-citation>
</ref>
<ref id="ref61">
<mixed-citation id="cit61" publication-type="journal"><name><surname>Grone</surname><given-names>B. P.</given-names></name>; <name><surname>Maruska</surname><given-names>K. P.</given-names></name> (<year>2016</year>) <article-title>Three Distinct Glutamate Decarboxylase Genes in Vertebrates</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>30507</fpage><pub-id pub-id-type="doi">10.1038/srep30507</pub-id>.<pub-id pub-id-type="pmid">27461130</pub-id></mixed-citation>
</ref>
<ref id="ref62">
<mixed-citation id="cit62" publication-type="journal"><name><surname>Lai</surname><given-names>F.</given-names></name>; <name><surname>Fagernes</surname><given-names>C. E.</given-names></name>; <name><surname>Nilsson</surname><given-names>G. E.</given-names></name>; <name><surname>Jutfelt</surname><given-names>F.</given-names></name> (<year>2016</year>) <article-title>Expression of genes
involved in brain GABAergic neurotransmission in three-spined stickleback
exposed to near-future CO<sub>2</sub></article-title>. <source/>Conserv.
Physiol.
<volume>4</volume>, <fpage>cow068</fpage><pub-id pub-id-type="doi">10.1093/conphys/cow068</pub-id>.<pub-id pub-id-type="pmid">28066553</pub-id></mixed-citation>
</ref>
<ref id="ref63">
<mixed-citation id="cit63" publication-type="journal"><name><surname>Lai</surname><given-names>F.</given-names></name>; <name><surname>Fagernes</surname><given-names>C. E.</given-names></name>; <name><surname>Jutfelt</surname><given-names>F.</given-names></name>; <name><surname>Nilsson</surname><given-names>G. E.</given-names></name> (<year>2017</year>) <article-title>Erratum: Expression
of genes involved in brain GABAergic neurotransmission in three-spined
stickleback exposed to near-future CO<sub>2</sub></article-title>. <source/>Conserv. Physiol.
<volume>5</volume>, <fpage>cox004</fpage><pub-id pub-id-type="doi">10.1093/conphys/cox004</pub-id>.<pub-id pub-id-type="pmid">28149521</pub-id></mixed-citation>
</ref>
<ref id="ref64">
<mixed-citation id="cit64" publication-type="journal"><name><surname>MacDonald</surname><given-names>R. B.</given-names></name>; <name><surname>Debiais-Thibaud</surname><given-names>M.</given-names></name>; <name><surname>Talbot</surname><given-names>J. C.</given-names></name>; <name><surname>Ekker</surname><given-names>M.</given-names></name> (<year>2010</year>) <article-title>The relationship between
dlx and gad1 expression indicates highly conserved genetic pathways
in the zebrafish forebrain</article-title>. <source/>Dev. Dyn.
<volume>239</volume>, <fpage>2298</fpage>–<lpage>2306</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.22365</pub-id>.<pub-id pub-id-type="pmid">20658694</pub-id></mixed-citation>
</ref>
<ref id="ref65">
<mixed-citation id="cit65" publication-type="journal"><name><surname>Higashijima</surname><given-names>S.-i.</given-names></name>; <name><surname>Mandel</surname><given-names>G.</given-names></name>; <name><surname>Fetcho</surname><given-names>J. R.</given-names></name> (<year>2004</year>) <article-title>Distribution
of prospective glutamatergic,
glycinergic, and GABAergic neurons in embryonic and larval zebrafish</article-title>. <source/>J. Comp. Neurol.
<volume>480</volume>, <fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/cne.20278</pub-id>.<pub-id pub-id-type="pmid">15515020</pub-id></mixed-citation>
</ref>
<ref id="ref66">
<mixed-citation id="cit66" publication-type="journal"><name><surname>Higashijima</surname><given-names>S.-i.</given-names></name>; <name><surname>Schaefer</surname><given-names>M.</given-names></name>; <name><surname>Fetcho</surname><given-names>J. R.</given-names></name> (<year>2004</year>) <article-title>Neurotransmitter properties of spinal
interneurons in embryonic and larval zebrafish</article-title>. <source/>J. Comp. Neurol.
<volume>480</volume>, <fpage>19</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1002/cne.20279</pub-id>.<pub-id pub-id-type="pmid">15515025</pub-id></mixed-citation>
</ref>
<ref id="ref67">
<mixed-citation id="cit67" publication-type="journal"><name><surname>Asad</surname><given-names>N.</given-names></name>; <name><surname>Deodato</surname><given-names>D.</given-names></name>; <name><surname>Lan</surname><given-names>X.</given-names></name>; <name><surname>Widegren</surname><given-names>M. B.</given-names></name>; <name><surname>Phillips</surname><given-names>D. L.</given-names></name>; <name><surname>Du</surname><given-names>L.</given-names></name>; <name><surname>Dore</surname><given-names>T. M.</given-names></name> (<year>2017</year>) <article-title>Photochemical Activation of Tertiary Amines for Applications
in Studying Cell Physiology</article-title>. <source/>J. Am. Chem. Soc.
<volume>139</volume>, <fpage>12591</fpage>–<lpage>12600</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b06363</pub-id>.<pub-id pub-id-type="pmid">28806084</pub-id></mixed-citation>
</ref>
<ref id="ref68">
<mixed-citation id="cit68" publication-type="journal"><name><surname>Asada</surname><given-names>H.</given-names></name>; <name><surname>Kawamura</surname><given-names>Y.</given-names></name>; <name><surname>Maruyama</surname><given-names>K.</given-names></name>; <name><surname>Kume</surname><given-names>K.</given-names></name>; <name><surname>Ding</surname><given-names>R.-g.</given-names></name>; <name><surname>Ji</surname><given-names>F. Y.</given-names></name>; <name><surname>Kanbara</surname><given-names>N.</given-names></name>; <name><surname>Kuzume</surname><given-names>H.</given-names></name>; <name><surname>Sanbo</surname><given-names>M.</given-names></name>; <name><surname>Yagi</surname><given-names>T.</given-names></name>; <name><surname>Obata</surname><given-names>K.</given-names></name> (<year>1996</year>) <article-title>Mice lacking
the 65 kDa isoform of
glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67
and GABA in their brains but are susceptible to seizures</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>229</volume>, <fpage>891</fpage>–<lpage>895</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.1898</pub-id>.<pub-id pub-id-type="pmid">8954991</pub-id></mixed-citation>
</ref>
<ref id="ref69">
<mixed-citation id="cit69" publication-type="journal"><name><surname>Eisen</surname><given-names>J. S.</given-names></name>; <name><surname>Smith</surname><given-names>J. C.</given-names></name> (<year>2008</year>) <article-title>Controlling morpholino
experiments: don’t stop
making antisense</article-title>. <source/>Development
<volume>135</volume>, <fpage>1735</fpage>–<lpage>1743</lpage>. <pub-id pub-id-type="doi">10.1242/dev.001115</pub-id>.<pub-id pub-id-type="pmid">18403413</pub-id></mixed-citation>
</ref>
<ref id="ref70">
<mixed-citation id="cit70" publication-type="journal"><name><surname>Stainier</surname><given-names>D. Y. R.</given-names></name>; <name><surname>Raz</surname><given-names>E.</given-names></name>; <name><surname>Lawson</surname><given-names>N. D.</given-names></name>; <name><surname>Ekker</surname><given-names>S. C.</given-names></name>; <name><surname>Burdine</surname><given-names>R. D.</given-names></name>; <name><surname>Eisen</surname><given-names>J. S.</given-names></name>; <name><surname>Ingham</surname><given-names>P. W.</given-names></name>; <name><surname>Schulte-Merker</surname><given-names>S.</given-names></name>; <name><surname>Yelon</surname><given-names>D.</given-names></name>; <name><surname>Weinstein</surname><given-names>B. M.</given-names></name>; <name><surname>Mullins</surname><given-names>M. C.</given-names></name>; <name><surname>Wilson</surname><given-names>S. W.</given-names></name>; <name><surname>Ramakrishnan</surname><given-names>L.</given-names></name>; <name><surname>Amacher</surname><given-names>S. L.</given-names></name>; <name><surname>Neuhauss</surname><given-names>S. C. F.</given-names></name>; <name><surname>Meng</surname><given-names>A.</given-names></name>; <name><surname>Mochizuki</surname><given-names>N.</given-names></name>; <name><surname>Panula</surname><given-names>P.</given-names></name>; <name><surname>Moens</surname><given-names>C. B.</given-names></name> (<year>2017</year>) <article-title>Guidelines for morpholino
use in zebrafish</article-title>. <source/>PLoS Genet.
<volume>13</volume>, <fpage>e1007000</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1007000</pub-id>.<pub-id pub-id-type="pmid">29049395</pub-id></mixed-citation>
</ref>
<ref id="ref71">
<mixed-citation id="cit71" publication-type="journal"><name><surname>Joris</surname><given-names>M.</given-names></name>; <name><surname>Schloesser</surname><given-names>M.</given-names></name>; <name><surname>Baurain</surname><given-names>D.</given-names></name>; <name><surname>Hanikenne</surname><given-names>M.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Motte</surname><given-names>P.</given-names></name> (<year>2017</year>) <article-title>Number of
inadvertent RNA targets
for morpholino knockdown in Danio rerio is largely underestimated:
evidence from the study of Ser/Arg-rich splicing factors</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>9547</fpage>–<lpage>9557</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx638</pub-id>.<pub-id pub-id-type="pmid">28934490</pub-id></mixed-citation>
</ref>
<ref id="ref72">
<mixed-citation id="cit72" publication-type="journal"><name><surname>Ding</surname><given-names>R.</given-names></name>; <name><surname>Tsunekawa</surname><given-names>N.</given-names></name>; <name><surname>Obata</surname><given-names>K.</given-names></name> (<year>2004</year>) <article-title>Cleft palate by picrotoxin or 3-MP
and palatal shelf elevation in GABA-deficient mice</article-title>. <source/>Neurotoxicol. Teratol.
<volume>26</volume>, <fpage>587</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2004.04.002</pub-id>.<pub-id pub-id-type="pmid">15203181</pub-id></mixed-citation>
</ref>
<ref id="ref73">
<mixed-citation id="cit73" publication-type="journal"><name><surname>Hagiwara</surname><given-names>N.</given-names></name>; <name><surname>Katarova</surname><given-names>Z.</given-names></name>; <name><surname>Siracusa</surname><given-names>L. D.</given-names></name>; <name><surname>Brilliant</surname><given-names>M. H.</given-names></name> (<year>2003</year>) <article-title>Nonneuronal
expression of the GABA(A) beta3 subunit gene is required for normal
palate development in mice</article-title>. <source/>Dev. Biol.
<volume>254</volume>, <fpage>93</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/S0012-1606(02)00030-1</pub-id>.<pub-id pub-id-type="pmid">12606284</pub-id></mixed-citation>
</ref>
<ref id="ref74">
<mixed-citation id="cit74" publication-type="journal"><name><surname>Zimmerman</surname><given-names>E. F.</given-names></name>; <name><surname>Wee</surname><given-names>E. L.</given-names></name> (<year>1984</year>) <article-title>Role of neurotransmitters
in palate development</article-title>. <source/>Curr. Top. Dev. Biol.
<volume>19</volume>, <fpage>37</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/S0070-2153(08)60394-4</pub-id>.<pub-id pub-id-type="pmid">6149892</pub-id></mixed-citation>
</ref>
<ref id="ref75">
<mixed-citation id="cit75" publication-type="journal"><name><surname>Wee</surname><given-names>E. L.</given-names></name>; <name><surname>Norman</surname><given-names>E. J.</given-names></name>; <name><surname>Zimmerman</surname><given-names>E. F.</given-names></name> (<year>1986</year>) <article-title>Presence
of γ-aminobutyric
acid in embryonic palates of AJ and SWV mouse strains</article-title>. <source/>J. Craniofacial Genet. Dev. Biol.
<volume>6</volume>, <fpage>53</fpage>–<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="ref76">
<mixed-citation id="cit76" publication-type="journal"><name><surname>Culiat</surname><given-names>C. T.</given-names></name>; <name><surname>Stubbs</surname><given-names>L. J.</given-names></name>; <name><surname>Woychik</surname><given-names>R. P.</given-names></name>; <name><surname>Russell</surname><given-names>L. B.</given-names></name>; <name><surname>Johnson</surname><given-names>D. K.</given-names></name>; <name><surname>Rinchik</surname><given-names>E. M.</given-names></name> (<year>1995</year>) <article-title>Deficiency of the beta 3 subunit of the type A gamma-aminobutyric
acid receptor causes cleft palate in mice</article-title>. <source/>Nat.
Genet.
<volume>11</volume>, <fpage>344</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1038/ng1195-344</pub-id>.<pub-id pub-id-type="pmid">7581464</pub-id></mixed-citation>
</ref>
<ref id="ref77">
<mixed-citation id="cit77" publication-type="journal"><name><surname>Miller</surname><given-names>R.
P.</given-names></name>; <name><surname>Becker</surname><given-names>B. A.</given-names></name> (<year>1975</year>) <article-title>Teratogenicity
of oral diazepam and diphenylhydantoin
in mice</article-title>. <source/>Toxicol. Appl. Pharmacol.
<volume>32</volume>, <fpage>53</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/0041-008X(75)90194-5</pub-id>.<pub-id pub-id-type="pmid">1135879</pub-id></mixed-citation>
</ref>
<ref id="ref78">
<mixed-citation id="cit78" publication-type="journal"><name><surname>Jurand</surname><given-names>A.</given-names></name>; <name><surname>Martin</surname><given-names>L. V. H.</given-names></name> (<year>1994</year>) <article-title>Cleft palate
and open eyelids inducing activity of
lorazepam and the effect of flumazenil, the benzodiazepine antagonist</article-title>. <source/>Pharmacol. Toxicol.
<volume>74</volume>, <fpage>228</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0773.1994.tb01103.x</pub-id>.<pub-id pub-id-type="pmid">8090691</pub-id></mixed-citation>
</ref>
<ref id="ref79">
<mixed-citation id="cit79" publication-type="journal"><name><surname>Wee</surname><given-names>E. L.</given-names></name>; <name><surname>Zimmerman</surname><given-names>E. F.</given-names></name> (<year>1983</year>) <article-title>Involvement
of GABA in palate morphogenesis and its
relation to diazepam teratogenesis in two mouse strains</article-title>. <source/>Teratology
<volume>28</volume>, <fpage>15</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/tera.1420280104</pub-id>.<pub-id pub-id-type="pmid">6635994</pub-id></mixed-citation>
</ref>
<ref id="ref80">
<mixed-citation id="cit80" publication-type="journal"><name><surname>Aarskog</surname><given-names>D.</given-names></name> (<year>1975</year>) <article-title>Association
between maternal intake of diazepam and oral clefts</article-title>. <source/>Lancet
<volume>306</volume>, <fpage>921</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(75)92153-4</pub-id>.</mixed-citation>
</ref>
<ref id="ref81">
<mixed-citation id="cit81" publication-type="journal"><name><surname>Safra</surname><given-names>M. J.</given-names></name>; <name><surname>Oakley</surname><given-names>G. P.</given-names><suffix>Jr.</suffix></name> (<year>1975</year>) <article-title>Association between cleft lip with
or without cleft palate and prenatal exposure to diazepam</article-title>. <source/>Lancet
<volume>306</volume>, <fpage>478</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(75)90548-6</pub-id>.</mixed-citation>
</ref>
<ref id="ref82">
<mixed-citation id="cit82" publication-type="journal"><name><surname>Saxen</surname><given-names>I.</given-names></name>; <name><surname>Saxen</surname><given-names>L.</given-names></name> (<year>1975</year>) <article-title>Association between maternal intake
of diazepam and oral clefts</article-title>. <source/>Lancet
<volume>306</volume>, <fpage>498</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(75)90567-X</pub-id>.</mixed-citation>
</ref>
<ref id="ref83">
<mixed-citation id="cit83" publication-type="journal"><name><surname>Rosenberg</surname><given-names>L.</given-names></name>; <name><surname>Mitchell</surname><given-names>A. A.</given-names></name>; <name><surname>Parsells</surname><given-names>J. L.</given-names></name>; <name><surname>Pashayan</surname><given-names>H.</given-names></name>; <name><surname>Louik</surname><given-names>C.</given-names></name>; <name><surname>Shapiro</surname><given-names>S.</given-names></name> (<year>1983</year>) <article-title>Lack of relation of
oral clefts to diazepam use during
pregnancy</article-title>. <source/>N. Engl. J. Med.
<volume>309</volume>, <fpage>1282</fpage>–<lpage>1285</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198311243092103</pub-id>.<pub-id pub-id-type="pmid">6633586</pub-id></mixed-citation>
</ref>
<ref id="ref84">
<mixed-citation id="cit84" publication-type="journal"><name><surname>Loescher</surname><given-names>W.</given-names></name> (<year>1979</year>) <article-title>3-Mercaptopropionic
acid: convulsant properties, effects on enzymes of the γ-aminobutyrate
system in mouse brain and antagonism by certain anticonvulsant drugs,
aminooxyacetic acid and gabaculine</article-title>. <source/>Biochem.
Pharmacol.
<volume>28</volume>, <fpage>1397</fpage>–<lpage>1407</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(79)90443-X</pub-id>.<pub-id pub-id-type="pmid">444305</pub-id></mixed-citation>
</ref>
<ref id="ref85">
<mixed-citation id="cit85" publication-type="journal"><name><surname>Rodriguez
de Lores Arnaiz</surname><given-names>G.</given-names></name>; <name><surname>Alberici de Canal</surname><given-names>M.</given-names></name>; <name><surname>Robiolo</surname><given-names>B.</given-names></name>; <name><surname>Mistrorigo
de Pacheco</surname><given-names>M.</given-names></name> (<year>1973</year>) <article-title>Effect of the convulsant 3-mercaptopropionic acid on
enzymes of the γ-aminobutyrate system in the rat cerebral cortex</article-title>. <source/>J. Neurochem.
<volume>21</volume>, <fpage>615</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1973.tb06006.x</pub-id>.<pub-id pub-id-type="pmid">4147501</pub-id></mixed-citation>
</ref>
<ref id="ref86">
<mixed-citation id="cit86" publication-type="journal"><name><surname>Leweke</surname><given-names>F. M.</given-names></name>; <name><surname>Louvel</surname><given-names>J.</given-names></name>; <name><surname>Rausche</surname><given-names>G.</given-names></name>; <name><surname>Heinemann</surname><given-names>U.</given-names></name> (<year>1990</year>) <article-title>Effects of
pentetrazol on neuronal activity and on extracellular calcium concentration
in rat hippocampal slices</article-title>. <source/>Epilepsy Res.
<volume>6</volume>, <fpage>187</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/0920-1211(90)90072-4</pub-id>.<pub-id pub-id-type="pmid">2272342</pub-id></mixed-citation>
</ref>
<ref id="ref87">
<mixed-citation id="cit87" publication-type="journal"><name><surname>Baraban</surname><given-names>S. C.</given-names></name>; <name><surname>Taylor</surname><given-names>M. R.</given-names></name>; <name><surname>Castro</surname><given-names>P. A.</given-names></name>; <name><surname>Baier</surname><given-names>H.</given-names></name> (<year>2005</year>) <article-title>Pentylenetetrazole
induced changes in zebrafish behavior, neural activity and c-fos expression</article-title>. <source/>Neuroscience
<volume>131</volume>, <fpage>759</fpage>–<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.11.031</pub-id>.<pub-id pub-id-type="pmid">15730879</pub-id></mixed-citation>
</ref>
<ref id="ref88">
<mixed-citation id="cit88" publication-type="journal"><name><surname>Tao</surname><given-names>L.</given-names></name>; <name><surname>Lauderdale</surname><given-names>J. D.</given-names></name>; <name><surname>Sornborger</surname><given-names>A. T.</given-names></name> (<year>2011</year>) <article-title>Mapping Functional Connectivity between
Neuronal Ensembles with Larval Zebrafish Transgenic for a Ratiometric
Calcium Indicator</article-title>. <source/>Front. Neural Circuits
<volume>5</volume>, <fpage>2</fpage><pub-id pub-id-type="doi">10.3389/fncir.2011.00002</pub-id>.<pub-id pub-id-type="pmid">21373259</pub-id></mixed-citation>
</ref>
<ref id="ref89">
<mixed-citation id="cit89" publication-type="journal"><name><surname>Dhir</surname><given-names>A.</given-names></name> (<year>2012</year>) <article-title>Pentylenetetrazol
(PTZ) kindling model of epilepsy</article-title>. <source/>Curr. Protoc.
Neurosci.
<volume>58</volume>, <fpage>9.37.31</fpage>–<lpage>39.37.12</lpage>. <pub-id pub-id-type="doi">10.1002/0471142301.ns0937s58</pub-id>.</mixed-citation>
</ref>
<ref id="ref90">
<mixed-citation id="cit90" publication-type="journal"><name><surname>Hewapathirane</surname><given-names>D. S.</given-names></name>; <name><surname>Dunfield</surname><given-names>D.</given-names></name>; <name><surname>Yen</surname><given-names>W.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Haas</surname><given-names>K.</given-names></name> (<year>2008</year>) <article-title>In vivo imaging
of seizure activity in a novel developmental seizure model</article-title>. <source/>Exp. Neurol.
<volume>211</volume>, <fpage>480</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.02.012</pub-id>.<pub-id pub-id-type="pmid">18402939</pub-id></mixed-citation>
</ref>
<ref id="ref91">
<mixed-citation id="cit91" publication-type="book"><person-group person-group-type="allauthors"><name><surname>Livingston</surname><given-names>R.</given-names></name></person-group> (<year>1971</year>) <article-title>Behavior of Photochromic Systems</article-title>. In <source/>Photochromism (<person-group person-group-type="editor"><name><surname>Brown</surname><given-names>G. H.</given-names></name></person-group>, Ed.), pp <fpage>13</fpage>–<lpage>44</lpage>, <publisher-name>Wiley</publisher-name>, <publisher-loc>New York</publisher-loc>.</mixed-citation>
</ref>
<ref id="ref92">
<mixed-citation id="cit92" publication-type="journal"><name><surname>Hatchard</surname><given-names>C. G.</given-names></name>; <name><surname>Parker</surname><given-names>C. A.</given-names></name> (<year>1956</year>) <article-title>A new sensitive chemical actinometer. II. Potassium
ferrioxalate as a standard chemical actinometer</article-title>. <source/>Proc. R. Soc. London, Ser. A
<volume>235</volume>, <fpage>518</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1098/rspa.1956.0102</pub-id>.</mixed-citation>
</ref>
<ref id="ref93">
<mixed-citation id="cit93" publication-type="book"><person-group person-group-type="editor"><name><surname>Westerfield</surname><given-names>M.</given-names></name></person-group>, Ed. (<year>2007</year>) <source/>The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio
rerio), <edition>5</edition>th ed., <publisher-name>University
of Oregon Press</publisher-name>, <publisher-loc>Eugene, OR</publisher-loc>.</mixed-citation>
</ref>
<ref id="ref94">
<mixed-citation id="cit94" publication-type="journal"><name><surname>Kimmel</surname><given-names>C. B.</given-names></name>; <name><surname>Ballard</surname><given-names>W. W.</given-names></name>; <name><surname>Kimmel</surname><given-names>S. R.</given-names></name>; <name><surname>Ullmann</surname><given-names>B.</given-names></name>; <name><surname>Schilling</surname><given-names>T. F.</given-names></name> (<year>1995</year>) <article-title>Stages
of embryonic development of the zebrafish</article-title>. <source/>Dev.
Dyn.
<volume>203</volume>, <fpage>253</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1002/aja.1002030302</pub-id>.<pub-id pub-id-type="pmid">8589427</pub-id></mixed-citation>
</ref>
<ref id="ref95">
<mixed-citation id="cit95" publication-type="journal"><name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Wloga</surname><given-names>D.</given-names></name>; <name><surname>Dougan</surname><given-names>S. T.</given-names></name> (<year>2011</year>) <article-title>Embryological manipulations in zebrafish</article-title>. <source/>Methods Mol. Biol.
<volume>770</volume>, <fpage>139</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-210-6_6</pub-id>.<pub-id pub-id-type="pmid">21805264</pub-id></mixed-citation>
</ref>
<ref id="ref96">
<mixed-citation id="cit96" publication-type="journal"><name><surname>Bill</surname><given-names>B. R.</given-names></name>; <name><surname>Petzold</surname><given-names>A. M.</given-names></name>; <name><surname>Clark</surname><given-names>K. J.</given-names></name>; <name><surname>Schimmenti</surname><given-names>L. A.</given-names></name>; <name><surname>Ekker</surname><given-names>S. C.</given-names></name> (<year>2009</year>) <article-title>A Primer for Morpholino Use in Zebrafish</article-title>. <source/>Zebrafish
<volume>6</volume>, <fpage>69</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1089/zeb.2008.0555</pub-id>.<pub-id pub-id-type="pmid">19374550</pub-id></mixed-citation>
</ref>
<ref id="ref97">
<mixed-citation id="cit97" publication-type="journal"><name><surname>Jutkiewicz</surname><given-names>E. M.</given-names></name>; <name><surname>Baladi</surname><given-names>M. G.</given-names></name>; <name><surname>Folk</surname><given-names>J. E.</given-names></name>; <name><surname>Rice</surname><given-names>K. C.</given-names></name>; <name><surname>Woods</surname><given-names>J. H.</given-names></name> (<year>2006</year>) <article-title>The convulsive
and electroencephalographic changes produced by nonpeptidic δ-opioid
agonists in rats: comparison with pentylenetetrazol</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>317</volume>, <fpage>1337</fpage>–<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.105.095810</pub-id>.<pub-id pub-id-type="pmid">16537798</pub-id></mixed-citation>
</ref>
<ref id="ref98">
<mixed-citation id="cit98" publication-type="journal"><name><surname>Peterson</surname><given-names>R. T.</given-names></name>; <name><surname>Fishman</surname><given-names>M. C.</given-names></name> (<year>2004</year>) <article-title>Discovery and use
of small molecules for probing biological
processes in zebrafish</article-title>. <source/>Methods Cell Biol.
<volume>76</volume>, <fpage>569</fpage>–<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-679X(04)76026-4</pub-id>.<pub-id pub-id-type="pmid">15602893</pub-id></mixed-citation>
</ref>
<ref id="ref99">
<mixed-citation id="cit99" publication-type="journal"><name><surname>Trapani</surname><given-names>J. G.</given-names></name>; <name><surname>Nicolson</surname><given-names>T.</given-names></name> (<year>2010</year>) <article-title>Physiological recordings
from zebrafish lateral-line
hair cells and afferent neurons</article-title>. <source/>Methods Cell
Biol.
<volume>100</volume>, <fpage>219</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-384892-5.00008-6</pub-id>.<pub-id pub-id-type="pmid">21111219</pub-id></mixed-citation>
</ref>
<ref id="ref100">
<mixed-citation id="cit100" publication-type="book"><person-group person-group-type="editor"><name><surname>Nüsslein-Volhard</surname><given-names>C.</given-names></name>, and <name><surname>Dahm</surname><given-names>R.</given-names></name></person-group>, Eds. (<year>2002</year>) <source/>Zebrafish: A Practical Approach, <publisher-name>Oxford University Press</publisher-name>, <publisher-loc>Oxford,
UK</publisher-loc>.</mixed-citation>
</ref>
<ref id="ref101">
<mixed-citation id="cit101" publication-type="book"><person-group person-group-type="allauthors"><name><surname>Harlow</surname><given-names>E.</given-names></name>, and <name><surname>Lane</surname><given-names>D.</given-names></name></person-group> (<year>1988</year>) <source/>Antibodies:
A Laboratory Manual, <publisher-name>Cold Spring Harbor Laboratory
Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>.</mixed-citation>
</ref>
<ref id="ref102">
<mixed-citation id="cit102" publication-type="book"><person-group person-group-type="allauthors"><name><surname>Sambrook</surname><given-names>J.</given-names></name>, and <name><surname>Russell</surname><given-names>D. W.</given-names></name></person-group> (<year>2001</year>) <source/>Molecular Cloning: A Laboratory Manual, <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>.</mixed-citation>
</ref>
<ref id="ref103">
<mixed-citation id="cit103" publication-type="journal"><name><surname>Bradford</surname><given-names>M. M.</given-names></name> (<year>1976</year>) <article-title>A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding</article-title>. <source/>Anal. Biochem.
<volume>72</volume>, <fpage>248</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id>.<pub-id pub-id-type="pmid">942051</pub-id></mixed-citation>
</ref>
<ref id="ref104">
<mixed-citation id="cit104" publication-type="journal"><name><surname>Kimmel</surname><given-names>C. B.</given-names></name>; <name><surname>Miller</surname><given-names>C. T.</given-names></name>; <name><surname>Kruze</surname><given-names>G.</given-names></name>; <name><surname>Ullmann</surname><given-names>B.</given-names></name>; <name><surname>BreMiller</surname><given-names>R. A.</given-names></name>; <name><surname>Larison</surname><given-names>K. D.</given-names></name>; <name><surname>Snyder</surname><given-names>H. C.</given-names></name> (<year>1998</year>) <article-title>The Shaping
of Pharyngeal
Cartilages during Early Development of the Zebrafish</article-title>. <source/>Dev. Biol.
<volume>203</volume>, <fpage>245</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1006/dbio.1998.9016</pub-id>.<pub-id pub-id-type="pmid">9808777</pub-id></mixed-citation>
</ref>
<ref id="ref105">
<mixed-citation id="cit105" publication-type="journal"><name><surname>Schneider</surname><given-names>C. A.</given-names></name>; <name><surname>Rasband</surname><given-names>W. S.</given-names></name>; <name><surname>Eliceiri</surname><given-names>K. W.</given-names></name> (<year>2012</year>) <article-title>NIH Image to ImageJ:
25 years of image analysis</article-title>. <source/>Nat. Methods
<volume>9</volume>, <fpage>671</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id>.<pub-id pub-id-type="pmid">22930834</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>